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ABSTRACT 
THE EFFECT OF NANOCLAYS ON THE PROPERTIES OF ASPIRIN 
MODIFIED ENTERIC POLYMER PREPARED BY HOT-MELT MIXING 
by 
Nonjaros Chomcharn 
Melt mixing in batch equipment or continuous extruders is a technique that recently 
gained the attention of the pharmaceutical industry. This dissertation investigates two 
controlled-release drug delivery systems. The first system, namely the enteric matrix, 
contains an active pharmaceutical ingredient (API) and plasticizer in an enteric polymer 
while in the second system a nanoclay is added to the enteric matrix, to produce a 
polymer nanocomposite. The first system employs hot-melt mixing to prepare a modified 
enteric matrix, as a delayed-release dosage form. Different concentrations of aspirin 
(ASP) ranging from 10 – 30% w/w are melt-mixed with a plasticized Eudragit
®
 L100-55 
in a batch mixer for 5 minutes at 100°C which is above the plasticized polymer’s glass 
transition temperature (Tg) and below the ASP’s melting point. Processing ASP with 
Eudragit
®
 L100-55 under these conditions does not promote hydrolysis of ASP. X-ray 
diffraction spectra obtained at room temperature reveal that the aspirin is present in a 
crystalline state. However, at elevated temperatures the dissolved aspirin displays a 
plasticizing effect by reducing the glass transition temperature (Tg) and lowering the 
viscosity of the polymer in proportion to its increasing concentration. The amount of ASP 
loading has no significant impact on the dissolution profiles. The samples meet USP 
delayed-release requirements and the API release mechanism is non-Fickian. 
 In the second system, polymer nanocomposites are produced by incorporating a 
nanoclay, hydrotalcite (HT). The morphology of HT in the nanocomposites, originally a 
ii 
multilayer structure, is significantly changed with increasing ASP loading. ASP shows 
affinity to the Al and Mg ions of the HT layers, resulting in a change of the HT 
morphology in the composites. The polymer chain of Eudragit
®
 L100-55 is also expected 
to be intercalated into HT layers but to a lesser extent. At low concentrations of ASP (5% 
and 10%w/w), ASP molecules penetrate the HT’s interlayers causing an expansion of its 
basal spacing (intercalation). The delamination (exfoliation) of HT in which the 
multilayer structure collapses and separates to individual platelets occurs at high ASP 
loading (30%w/w) with the formation of ASP metal salt. The dispersion of HT reduces 
the nanocomposites’ permeability and increases tortuosity as evidence by the 
significantly prolonged release of ASP with its release rate greatly depending on the HT 
morphology.   
In the third system, 10%-30%w/w of CAF was processed with plasticized 
Eudragit
®
 L100-55 under identical conditions as for the first system. CAF in crystalline 
form is observed in the API/polymer blends after cooling. The release rate of CAF 
(CAF/Eudragit
®
 L100-55) in pH 7.4 medium is slightly faster than ASP (ASP/Eudragit
®
 
L100-55) due its higher aqueous solubility. The fourth system is classified as polymer 
nanocomposites with a cationic API and an anionic nanoclay. MMT is present in an 
agglomerated phase in all nanocomposites. The CAF release in the pH 7.4 medium from 
CAF/MMT/Eudragit
®
 L100-55 is slightly slower compared to CAF/Eudragit
®
 L100-55. 
Therefore, the agglomeration of MMT does not significantly retard the release rate of 
CAF from the CAF/MMT/Eudragit
®
 L100-55. The lack of change of MMT morphology 
could be due to the low affinity of CAF to MMT since CAF is a weak base. 
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Polymer processing parameters are continuously studied in the plastics and related 
industries since polymers are the most common materials used in daily life applications; 
for instance, food containers, clothes, mobile phone cases, automotive tires and even 
airplane’s wings. Polymers are extensively employed due to a wide range of properties 
obtained by structure modification. Polymers are also of extreme importance in the 
pharmaceutical industry as excipients in different dosage forms which are, but not limited 
to tablets, capsules, creams and solutions. The use of polymers in film-coating processes 
demands a better understanding of their properties compared to plain tablet 
manufacturing. For such applications, this is similar to the requirements of the plastics 
industry where comprehensive polymer properties (melt viscosity, molecular weight, 
glass transition temperature, modulus, etc.) are fully evaluated before processing.  
In 2000, Abbott Laboratories adopted one polymer processing technique namely, 
hot-melt extrusion (HME) to prepare an amorphous solid dispersion, Kaletra
®
 which is a 
combination product containing lopinavir and ritonavir. Since the Active Pharmaceutical 
Ingredient (API) ritonavir exhibits low aqueous solubility, utilizing the SOLIQS 
Meltrex
®
 formulation technology, an amorphous solid dispersion of ritonavir in a matrix 
of Kollidon
®
 VA 64 and surfactants was designed to prepare a matrix with enhanced API 
solubility (Breitenbach, 2006). HME can solve several problems in pharmaceutical 





release of APIs and masking their unpleasant taste. It has been almost 20 years since the 
very first commercial product was manufactured by HME. However, very few products 
have been commercialized. One reason is that HME requires a high level of polymer 
processing and polymer property understanding which is developed by limited groups of 
researchers in the pharmaceutical industry. HME in pharmaceutics becomes more 
complicated due to the fact that a number of APIs are sensitive to elevated temperatures, 
resulting in more constrained process conditions (lower temperature and shorter residence 
time). Therefore, the fundamentals of polymer processing for pharmaceutical applications 
should be extensively addressed in order to achieve the full benefits of HME.  
The use of HME or hot melt mixing (HMM) to prepare a controlled-release 
polymer matrix is the focus of this dissertation. HMM is also a term involving materials 
mixing at elevated temperatures in a batch mixer. The APIs used in the present work have 
not been previously processed, to our knowledge by HMM or HME. In Chapter 2 of the 
dissertation, a review of available important literature on HME and modification of APIs 
for controlled release is discussed. Chapter 3 summarizes experimental methods that are 
used in this work. Two systems are investigated in Chapters 4 and 5: an enteric matrix 
and polymer nanocomposites based on anionic API. 
The first system (Chapter 4) investigates the feasibility of enteric matrix 
manufacturing prepared by HMM. The selected API is aspirin (ASP) since it is normally 
available as enteric-coated tablets. ASP’s initial degradation temperature is 150°C and 
becomes even lower in the presence of moisture. Therefore, ASP is an appropriate 
candidate API for incorporation in an enteric matrix preparation. ASP is processed with 
an enteric polymer, Eudragit
®





mixer. Dissolution analysis using mathematical models are also employed in this 
Chapter. In Chapter 5, the second system which is an extension of work from the first 
system is reported. The enteric matrix properties are examined when an additional 
excipient, nanoclays, is added. In general, polymer permeability can be reduced by the 
dispersed platelets of nanoclays. The reduced permeability could lead to a modified-
release or to be more specific, a prolonged-release profile.    Hydrotalcite (HT) nanoclay 
is chosen since it is used as API itself and as a carrier for controlled-release systems. 
Therefore, HT would be very compatible with drug delivery systems.  
Chapter 7 and 8 describe the initial experiments involving polymer 
nanocomposites in a cationic system. Caffeine (CAF) and montmorillonite (MMT) are 
used as API and nanoclays, respectively while the polymer base is still Eudragit
®
 L100-
55. The purpose of the cationic system is to compare the nanoclay’s morphology and 
dissolution profile with anionic system. Hence, materials characterization is not fully 
conducted as anionic system.   The developed data are summarized along with future 








2.1 Solid Dispersions and Limit of Miscibility/Solubility 
It is estimated that about 40% of the new chemical entities (NCE) being discovered are 
poorly water-soluble (Lipinski, 2001). Solubility, especially in aqueous systems is an 
important physicochemical property of API’s. To enter the human body’s blood 
circulation, the API has to be dissolved and absorbed through the gastrointestinal tract. 
Improving API’s solubility is a critical key to promote API dissolution and therefore, its 
therapeutic efficacy. Solid dispersions are known as an effective method enhancing 
dissolution of hydrophobic API’s 
Solid dispersions are defined as a group of solid products consisting of at least 
two different components, generally a hydrophilic matrix and a hydrophobic drug. 
(Dhirendra et al., 2009)  The matrix can be either crystalline or amorphous. The drug can 
be dispersed molecularly, as amorphous particles (clusters) or as crystalline particles. 
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Partially miscible, 2 phases even 








Molecular diameter of drug (solute) 
differs less than 15% from the 
matrix (solvent) diameter. In that 
case the drug and matrix are 
substitutional. Can be continuous or 
discontinuous. When discontinuous: 
2 phases even though drug is 
molecularly dispersed. 





Drug (solute) molecular diameter 
less than 59% of matrix (solvent) 
diameter. Usually limited 






Particle size of dispersed phase 
dependent on cooling/evaporation 
rate. Obtained after crystallization 






Particle size of dispersed phase 
dependent on cooling/evaporation 
rate; many solid dispersions are of 
this type. 
2 
VI Glass solution A M 
Requires miscibility OR solid 
solubility, complex formation or 
upon fast cooling OR evaporation 
during preparation. 
1 
*A: matrix in an amorphous state, C: matrix in a crystalline state 
**: A: drug dispersed as amorphous clusters in the matrix, C: drug dispersed as crystalline particles in the 






The ultimate solubility enhancement can be achieved when the API is molecularly 
dispersed in the polymer chosen as a carrier, which can be obtained in two solid 
dispersion types: type III (solid solution) and type VI (glass solution). It has been 
suggested that a thermodynamically stable formulation is obtained when the drug is 
completely dissolved below its saturation solubility in the polymer, resulting in solid 
solution and glass solution (Kolter et al., 2010). When the drug concentration exceeds the 
saturation level, the whole system is only kinetically controlled since the API may 
crystallize or precipitate out of the polymer during storage. Glass suspensions in which 
both API and polymer are in amorphous phase are also kinetically controlled because the 
API is dispersed in an amorphous polymer and may crystallize whereas the polymer 
matrix containing crystalline API is quite stable. Therefore, the solubility limit of API in 
the selected polymer is a strong factor determining solid dispersion type and its stability 
(Kolter et al., 2010).      
Hildebrand and Scott established fundamental solubility parameters which can be 
used as a tool predicting the miscibility of the components of the formulations (Hansen 
2007). The Hildebrand solubility parameter is defined as the square root of cohesive 
energy density: 
 
   
 
 
     
(2.1) 
 
Where V is the molar volume of the pure solvent and E is its (measurable) energy of 





(atomic) dispersion forces, (molecular) permanent dipole-permanent dipole forces, and 
(molecular) hydrogen bonding (electron exchange) (Hansen, 2007).   
  Hansen has proposed the calculation of solubility parameters based on the total 
cohesion energy (Hansen, 2007). The total cohesion energy, E, must be the sum of the 
individual energies (dispersion, polar, H-bonding) that make it up. 
 
                        E = ED + Ep +EH (2.2) 
  
Dividing this by the molar volume gives the square of the total (or Hildebrand) 
solubility parameter as the sum of the squares of the Hansen D, P and H components. 
 
               E/V = ED/V + Ep/V +EH/V (2.3) 
 










The solubility parameters can also be determined by other experimental methods, 
for instance, inverse gas chromatography and calorimetry (Egawa et al., 1992; Rey-
Mermet et al., 1991, Huu-Phuoc et al., 1987). Regardless of methods used to measure 
solubility parameters, predictions of solubility are similar.  If the difference in solubility 
parameters between polymer and plasticizer, or polymer and API is <7.0 MPa
1/2
, the two 
components are likely to be miscible and form a solid glassy solution; if >10 MPa
1/2
, they 
are likely to be immiscible, and the formation of a solid glassy solution is unlikely 





particularly dependent on properties such as water activity, polydispersity, molecular 
weight, temperature, etc. Nonetheless, the listed values may be used as a screening tool 
for solubility estimation. 
 
 
2.2 Hot-melt Extrusion (HME) 
Hot-melt extrusion (HME) has gained interest in the pharmaceutical industry due to its 
potential to resolve the issue of limited solubility of many nominally water-soluble APIs. 
HME is a process where API and polymer are melted/ softened, followed by kneading 
under elevated temperatures and pressures and then forcing through an orifice by screw 
action (Kolter et al., 2010). Since the process involves the melting of different 
thermoplastic materials with API in the barrel of the extruder, HME can deliver a 
polymer matrix with different properties for various applications. Wide range advantages 
of HME are listed in Table 2.2. 
 
Table 2.2 Advantages of HME (Kolter et al., 2010) 
Problem Solution by HME 
Poor bioavailability due to poor API 
solubility 
Use of HME to prepare solid solution/ 
dispersion 
Poor API stability during processing 
caused by hydrolysis 
Use of HME as alternative to wet 
agglomeration (no hydrolytic stress) 
Unreliable sustained release action 
Use of HME to prepare sustained release 
dosage forms (single/ multiple units) 
Poor stability or tolerability of API in 
the stomach 
Use of HME to prepare enteric release 
dosage forms 
Poor taste of API 
Use of HME to prepare taste-masked 
dosage forms 
Manufacturing of films 








The effect of three process parameters associated with HME, i.e., mixing 
temperatures, screw rotational speeds, and residence times on indomethacin (INM)-
Eudragit
®
 EPO extrudate was investigated (Huiju et al., 2010). From the system’s 
dynamic dissolution behavior, increasing set temperature and screw speed enhanced 
dissolution rate of indomethacin in the batch mixer and in the co-rotating twin-screw 
extrusion studies. It was concluded that the dissolution of APIs in a polymeric excipient 
melt is a laminar forced convective diffusion process, and that laminar distributive 
mixing can significantly enhance the dissolution process. In addition, it was concluded 
that the kneading blocks may be the most important equipment design parameter during 
co-rotating twin-screw extrusion controlling the full dissolution of the drug in the 
polymer melt. The release of INM from the Eudragit
®
 EPO extrudate in pH 1.2 medium 
was significantly improved compared to pristine INM due to the amorphous state of INM 
in the extrudate samples.  
 The downstream operations can modify the properties of the extrudate prepared 
by HMM and HME. The impact of foaming on dissolution of Soluplus
®
 containing 
30%w/w INM, which was obtained by HMM was studied (Terife et al., 2012). INM 
found in amorphous form in unfoamed HMM samples had faster release rate in pH 7.4 
medium compared to pure INM. With the foaming process using supercritical CO2 as the 
physical blowing agent (PBA) at 100°C and 9.65 MPa the release of INM from foamed 
samples was even faster. The improved release rate suggested by the authors was caused 
by enhanced solvent absorption rate through the foamed disks due to higher surface area 






2.3 HME Using Enteric Polymers (Eudragit
®
 L100-55) 
Enhancing solubility is not the only advantage of HME; HME can also prepare sustained 
release and enteric dosage forms by dispersing the API in a suitable polymer matrix. 
Enteric properties of tablets/ pellets are conventionally obtained by film-coating with a 
pH-dependent polymer such as the copolymer of methacrylic acid and ethyl acrylate 
available as Kollicoat
®
 MAE 100P (BASF) or Eudragit
®
 L100-55 (Evonik). HME can 
provide an enteric matrix with substantially lower manufacturing time and cost since 
fewer unit operations and no solvents are required.   
Andrews et al., prepared hot-melt extruded enteric tablets using a single-screw 
Randcastle Microtruder extruder (model RCP-0750) fitted with an 8 mm die (Andrews et 
al., 2008). 5-aminosalicylic acid was processed with Eudragit
®
 L100-55 and the 
temperatures of the four heating zones were maintained at 95, 105, 110 and 115°C. 
Triethyl citrate (TEC) and citric acid were employed as liquid and solid plasticizers, 
respectively. The effects of gelling agent, polyvinylpyrrolidone (PVP K30) and 
polyacrylic acid (Carbopol 971P NF) were also investigated. HME tablets showed 
excellent gastro-resistance. Drug release from HME tablets was dependent on the 
concentration of TEC, citric acid, PVP K30 and Carbopol 971P NF. The incorporation of 
the gelling agent significantly reduced the erosion of the matrix and drug release rate at 
pH 6.8, resulting in slower release rate. However, the gastro-resistant property was lost 
due to the formation of channels within the tablets.  
Bruce et al. reported that hot-melt extruded guaifenesin tablets showed crystal 
growth on the surface of the extrudate (Bruce et al., 2007).  Eudragit
®
 L100-55, TEC and 





guaifenesin solubility in Eudragit
®
 L100-55 was found to be 25%w/w.   Hydrophilic 
polymeric additives including PVP K25, polycarbophil, PEG 3350, poloxamer 188 were 
added as crystal growth inhibitors; the extent of crystal growth was reduced for all 
additives. The addition of hydrophilic additives was expected to alter the dissolution of 
Eudragit
®
 L100-55 from only erosion to swelling/erosion. However, the formulations 
containing 10%w/w hydrophilic additive did not swell during dissolution and therefore 
has no effect on the API release compared to formulations without hydrophilic additives. 
Hughey et al. developed dissolution-enhanced solid dispersions of Roche 
Research Compound A (ROA) using a HAAKE Minilab II Microcompounder equipped 
with 5/14-mm conical screws (Hughey et al., 2010). The compound classified as BCS 
class II was chemically unstable at elevated temperatures and acidic pH values. Eudragit
®
 
L100-55 dispersions prepared by HME at 140°C required the use of micronized ROA and 
reduced residence times in order to render ROA amorphous. The dissolution of ROA was 
significantly increased in neutral pH compared to crystalline ROA.  
The preparation of theophylline (water soluble API) enteric matrix systems with 
different plasticizers including TEC, acetyltributyl citrate (ATBC), citric acid 
monohydrate, polyethylene glycol 8000 and methyl paraben was examined by Schilling 
and coworkers (Schilling et al., 2010). The investigated polymers were cellulosic 
polymers (Aqoat
®
 LF and HF) and acrylic polymers (Eudragit
®
 S100, L100 and L100-
55). A mini extruder equipped with two co-rotating screws was used. Cellulosic polymers 
demonstrated lower melt viscosities during extrusion compared to polymethacrylate 
polymers due their lower molecular weight and lower Tg. A cellulosic extrudate 





acid stage than the extrudate prepared with polymethacrylates with more than 20% drug 
released after 2 hours. The use of a less soluble plasticizer such as ATBC was suggested 
to reduce drug release. Cellulosic polymers are more hydrophilic than polymethacrylates 
enhancing faster water penetration and more extensive hydration. This could lead to 
increased matrix permeability and drug diffusion rates even in the acid stage. In the 
buffer phase, the polymethacrylate pellets exhibited a more sustained-release profile; this 
behavior was attributed to the larger molecular weight and slower hydration and erosion 
characteristics.  
 
2.4 Aspirin and Caffeine 
Aspirin (ASP) is widely used for multiple indications depending on the dosage regimen. 
High-dose ASP (325 – 500 mg) is prescribed for pain relief whilst low-dose ASP (60 – 
81 mg) is intended to prevent cardiovascular events (Angiolillo et al., 2008). Both 
strengths are currently available as enteric-coated tablets due to their common side effect, 
i.e., gastric irritation. Literature studies of HME with ASP are very limited since ASP has 
relatively high water solubility. ASP is sensitive to moisture and gradually decomposes in 
aqueous solution through hydrolysis to salicylic acid and acetic acid (Florey, 1979; Lund, 
1994). Therefore, dry granulation is commonly used to prepare ASP tablets to avoid 
exposure to moisture (Erum et al., 2011; Troy, 2006).  
The hydrolysis of ASP can occur due to the incompatibility with other excipients. 
El-Banna et al. reported that when ASP was incorporated in physical mixture with 





storage conditions (El-Banna et at., 1978). The authors suggested that the acceleration 
rate may be due to the hygroscopic character of the PVP.  
The interactions between the amino groups of cationic methylmethacrylate 
polymers, generally used as enteric coating materials and ASP should be considered.  
Note that ASP has undergone hydrolysis when processing with Eudragit
®
 RL and RS100, 
a cationic polymer containing quaternary ammonium groups (Petereit et al., 1999).  
Caffeine (CAF) is available in tablets ranging from 65-200 mg. It is used as 
stimulant for central nervous system from the group of xanthine derivatives and can be 
used to impart a desired level of increased alertness (McLellan et al., 2005). The 
sustained-release of CAF from a polymeric tablet matrix using poly(ethylene oxide) was 
developed by Tan and coworkers (Tan et al., 2006). The CAF-poly(ethylene oxide) tablet 
exhibited less burst release in simulated intestinal fluid compared to other polymers.  
McGinity and Lach studied the adsorption of CAF to MMT prepared by ion-exchange 
(McGinity and Lach, 1976). CAF was bounded moderately to MMT and the 1:5 complex 
of CAF and MMT released 42% of the drug into the dissolution 0.1 N HCl medium. 
 
 
2.5 Clays in the Pharmaceutical Industry 
Clays are used as APIs for a wide range of indications. For oral administration, their 
remedies are but not limited to antacids, gastrointestinal protectors, antidiarrhoeaics, 
osmotic oral laxatives, homeostatics, direct emetics, antianemics and mineral 
supplements. They may also be used topically as antiseptics, disinfectants, 
dermatological protectors, anti-inflammatories, local anesthetics, keratolytic reducers and 





Clays are also employed as pharmaceutical excipients playing several roles 
according to their structural and physico-chemical properties. Carretero and Pozo (2009) 
summarized the clay properties and their use as follows: 
(1) High adsorption capacity and specific surface area for use as carriers and 
releasers of API and flavor correctors 
(2) Propensity to take up water and decompose in acid media, for use as 
disintegrants and desiccants 
(3) Unctuousness for use as lubricants 
(4) Thixotropic and colloidal properties for use as emulsifying, thickening and 
anticaking agents 
(5) Slight alkaline reaction (pH) and plasticity for use as diluents and binders 
(6) Solubility in water, giving solutions with osmotic pressure similar to that of 
corporal liquids, for use as isotonic agents 
(7) Opaqueness and color for use as opacifiers and pigments  
 
2.6 Hydrotalcite and Montmorillonite  
Hydrotalcite (HT) is one of several layered-double hydroxide (LDH) materials 
designating synthetic or natural layer/lamellar hydroxides with two kinds of metallic 
cations in the main layers and interlayer domains containing anionic species (Roy et al., 
2001). HT is the LDH consisting of Mg as divalent and Al as trivalent cations. The 
positive charge of the main layers counterbalanced by the negative charge of interlayered 
anions is the key in maintaining the LDH structure; therefore, LDHs are classified as 





layers. One major characteristic of LDHs is their ability to exchange interlayered anions 
with guest anions if the latter have higher affinity to the cationic main layers. This 
phenomenon is called intercalation; cationic clays such as montmorillonite also possess 
similar ion exchange characteristics but with opposite charge. Having this property, HT 









, etc. from waste water as well as in the neutralization 
and thermal stabilization of halogen-containing polymers (Mitaya, 1983).   
In another application taking advantage of the HT’s ion exchange property and its 
multilayer structure, several researchers investigated API/nanoclay hybrids by employing 
LDH as a carrier intercalated by API; in these systems the API release profile and API 
solubility were modified. Different methods have been suggested to prepare LDH and 
API/ nanoclay hybrids (Costantino et al., 2008). They can be summarized as follows 
(Arco et al., 2007; Roy et al., 2001): 
(1) Co-precipitation – it is based on the slow addition of a mix solution of 
divalent and trivalent metal salts in adequate proportion into a reactor 
containing water or other appropriate solvents. To prepare API/ nanoclay 
hybrids, the API can be added in the reactor and become the intercalated 
species. An optional solution is added in the reactor in order to maintain the 
pH at a selected value leading to the co-precipitation.    
(2)  Calcination and reconstruction – by heating the LDH in the furnace at 
approximately 500°C, surface water is first lost, then the interlamellar water 
molecules and finally, roughly in the 200-350°C range, water corresponding 





structure. Carbon dioxide may also be removed if carbonate anions were 
initially present. The entire process is named calcination and the consequent 
product is called calcined LDH. The reconstruction can take place in a 
solution containing new ions, such as dissolved API to be intercalated under 
controlled conditions.  
(3) Ion exchange – exchange in LDH depends mainly on the electrostatic 
interaction between the positively charged hydroxylate sheets and the 
exchange anions, and to a lesser extent, on the free energy involved in the 
changes of hydration. Exchange is therefore favored for in-going anions with 
a higher charge density. The rate limiting step for this method is the diffusion 
of the in-going anions within the interlayer which could also be prevented by 
a too small basal spacing. Hence, the selected in-going anions/ API must 
possess high charge density and adequate molecular size.  
Carja et al. have intercalated ASP to LDH by two methods (Carja et al., 2007). 
The first method is based on direct co-precipitation synthesis of ASP-HT nano-hybrids in 
aqueous solution of Mg and Al salts. An ethanol-aqueous solution of ASP was added 
drop-wise at a constant pH of 8.5. The second method is based on the reconstruction 
method in which calcined LDH was added to a water-ethanol ASP solution. Both 
methods successfully delivered ASP-intercalated LDH but the sample obtained by co-
precipitation appeared to be more crystalline than the sample prepared by reconstruction 
according to XRD results. The asymmetric stretching of interlayer carbonate (COO
-
) of 






Hong and Weng-gong prepared drug-containing LDH (MgAlZn-Asp-LDH) by 
the co-precipitation method with ASP (Hong and Weng-gong, 2010). Magnesium (II) 
was partially replaced by zinc (II) in the hydrotalcite-like layers, and ASP was dispersed 
into the interlayer region. Due to the increase of HT basal spacing to 1.32 nm, the authors 
suggested the conformation of intercalated ASP as vertically-arranged monolayer ASP. 
ASP was present as ionized form (COO
-
) and this carboxylate group was bound to the 
Zn
2+
 through oxygen atoms. In dissolution under pH 7.4 medium, it showed biphasic 
release pattern, with an early burst release of ASP (48.3% of ASP released after the first 
1.2 hours) followed by a relatively slower release (46.8% of ASP released after 51 
hours). The initial burst release may be attributed to the ASP being weakly adsorbed on 
the outer surface of LDH; the slow release of the rest of ASP can be due to the strong 
interaction between aspirin molecules and the lamella host. 
Ambrogi et al. synthesized HT in chloride form by co-precipitation method and 
performed intercalation reaction with ibuprofen (Ambrogi et al., 2001). The reaction took 
place in a Gallen Kamp orbital incubator type INR2000 at 60°C for 3 days. The 
ibuprofen-intercalated HT was successfully produced and this was confirmed by the 
increase of the interlayer spacing from 0.78 nm to 2.17 nm. The authors suggested that 
the ibuprofen ions were accommodated in the interlayer as a monolayer. The drug release 
profile in simulated intestinal fluid showed that 60% of the API was released after 20 
minutes and 100% after 100 minutes. The rapid release during the first 20 minutes could 
be the free ibuprofen while the latter sustained-release was due to intercalated ibuprofen 









 which both are able to intercalate into HT. Therefore, the intercalated ibuprofen 
was gradually replaced by phosphate anions and dissolved in the buffer. 
Mefenamic and meclofenamic have been intercalated into HT by three different 
methods: (1) coprecipitation (2) reconstruction (3) ion exchange from HT in the chloride 
form (Arco et al., 2007). Intercalation has been achieved by all three methods and the 
gallery height was expanded to approximately 2.20 nm in most cases. Elemental analysis 
determined the drug loading which ranged from 42% to 54% for mefenamic and 39% to 
54% for meclofenamic. According to FTIR spectra, mefenamic was in intercalated 
anionic forms in which the carboxylate groups were oriented towards the brucite-type 
layers to enhance the electrostatic interaction. The use of LDH enhanced the apparent 
solubility of mefenamic in mefenamic-LHD hybrid at three pH values tested, 1.2, 4.5 and 
6.8. The mefenamic-LDH hybrid had a slower release rate compared to pure API and a 
physical mixture with LDH at all pH values tested (Arco et al., 2008). 
Montmorillonite (MMT) is one of the most widely used species in the smectite 
group of clays (Carretero and Pozo, 2009). Various grades of MMT were studied for use 
as disintegrants, binders and lubricants for solid dosage forms (Wai et al., 1966) while it 
is commonly used in suspensions as thickening agent/suspending agents in liquid dosage 
forms. The use of MMT to modify the release of API is reported.  
The adsorption of various APIs to MMT was investigated by McGinity and Lach 
(McGinity and Lach, 1976). The studied APIs were cationic APIs (chlorpheniramine 
maleate, amphetamine sulfate, propoxyphene HCl), anionic APIs (sodium salicylate and 
sulfanilamide), amphoteric APIs or nonionic APIs (theophylline and CAF). Dissolution 





of API bound by one unit of MMT varied considerably. Anionic APIs, on the contrary, 
were bound weakly. The authors suggested the binding mechanism of cationic APIs to 
MMT as a two-step process: a cationic-exchange reaction followed by strong surface 
chemisorption. 
 Dapsone-intercalated MMT was successfully prepared by ion exchange at room 






) was employed as a carrier for the 
API. The loading of intercalated dapsone in MMT was found to be approximately 10%. 
Two phases of dapsone release profile were obtained in the dissolution test under pH 7.4 
medium. In the first 30 minutes, fast release rate was observed due to the dapsone 
adhered/coated on the MMT’s surface. After that, the release was slowed down indicating 
the release of dapsone from the MMT interspacing. 
MMT was used to modify the release rate of acetaminophen-poly(ethylene oxide) 
solid dispersion prepared by HMM (Yang et al., 2010). Two types of MMT (Cloisite
®
 
15A and 30B) were added to the binary mixture of API and polymer at the ratio of 
10%w/w. The presence of either nanoclay dramatically accelerates the drug’s 
recrystallization rate and slows down the drug’s releasing rate. The drop of the releasing 
rate is mainly due to the decrease of wettability, as supported by the contact angle data. 
Data analysis of the dissolution results suggests that the addition of nanoclays changes 









2.7 Polymer Nanocomposites 
Polymer nanocomposites are one of the breakthrough materials used in plastic-based 
components such as automotive, electronics, biomedical devices and safety equipment 
(Jeon and Baek, 2010; Paul and Robeson, 2008).  In general, the addition of fillers to the 
polymer base affects numerous properties, for example, stiffness, toughness, flexural 
modulus, permeability and heat resistance (Xanthos, 2010). Nanocomposites are the 
particle-filled composites in which at least one dimension of the dispersed particles is in 
the nanometer range (Alexandre and Dubois, 2000).  
Toyota researchers were the first group that successfully developed clay-polymer 
composite materials such as a nylon 6-clay hybrids using in situ polymerization (Kojima 
et al., 1993; Usuki et al., 1993). The nylon polymer chain was intercalated into 
montmorillonite, resulting in increased basal spacing. The authors suggested that the 
ammonium cations (-NH3
+
) in nylon 6 interact with the anions in montmorillonite.  The 
new composites of nylon 6 and silicate layers of montmorillonite developed were found 
superior in strength, modulus and heat distortion to pure nylon 6. This achievement has 
led to an extension of research in clay-based nanocomposites due to significant 
mechanical property advantages (Paul and Robeson, 2008; Fornes, 2002). 
Nylon 6-clay hybrids can also be prepared by direct melt compounding of 
polymers with clays. Cho and Paul prepared Nylon 6-organoclay nanocomposites using a 
conventional single and a twin screw extruder (Cho and Paul, 2001). To achieve a better 
interaction with the organic polymers, the cations (typically sodium) present in 
montmorillonite to balance the net negative charge of aluminum/magnesium silicate 





as quaternary ammonium salts to produce an organoclay. Then, the organoclay was melt 
compounded with nylon 6. The single screw extrusion could not deliver full exfoliation 
because the amount of shear is insufficient and the residence time is too short. 
Consequently, the final product is a mixture of exfoliated and unchanged clay.  A high 
degree of exfoliation was obtained by twin screw extrusion. The authors reported 
continuous improvement in strength and modulus relatively to the neat nylon 6 matrix as 
more organoclay was added.  It was suggested by Durmus and coworkers that the high 
degree of exfoliation of nylon 6/clay composites is due to the strong interactions, 
specifically  hydrogen bonds, between the polar polymer chains and the organically 
modified clay (organoclay) layers (Durmus et al., 2007).  
Generally, the clay structure can be present in the polymer nanocomposites in 
three phases: agglomeration, intercalation, and exfoliation as shown in Figure 2.1 (Paul 
and Robeson, 2008). The agglomeration state is the original structure in which the entire 
structure is constituted by the stacking of layers, forming aggregates of tactoids.  The 
XRD of the polymer nanocomposites would show unchanged spectra compared to pure 
clays whilst large tactoids are depicted in Transmission Electron Microscopy (TEM). In 
the intercalation state the basal spacing of the clay is expanded by the guest species 
which can be ions or polymer chains. The XRD peak of clays in the nanocomposites is 
shifted to lower angle, indicating an increased basal spacing between the main layers. For 
exfoliation, the stacks of layers are completely separated and dispersed individually as a 
sheet/ platelet in the nanocomposites. Therefore, no XRD spectra are shown since there is 
no crystal structure formed by layers of clays anymore. The final structure of clays in the 





compatibilizer (if needed), and clay platelets.   To maximize a particular property by 
adding selected nanoclays, several researchers proposed that an exfoliated state of the 
nanoclays should be achieved due to the substantially high surface area of clay platelets 
dispersed in the polymer matrix (Paul and Robeson, 2008; Marchant and Jayaraman, 
2002). Figure 2.2 is the schematic of a polymer-clay nanocompoistes with completely 




Figure 2.1  Illustration of different state of nanoclays in polymers and the corresponding 










Figure 2.2 Illustration of polymer-clay nanocomposites with completely exfoliated clay 
sheets (Fischer, 2003). 
 
In the polymer nanocomposites field, HT was employed as filler in several 
polymers to modify their original properties for particular applications, for example, 
poly(vinyl chloride), polypropylene, poly(methyl methacrylate) (Ardanuy et al., 2010; 
Manzi-Nshuti et al., 2009; Huang and Wang, 2009; Bao et al., 2006).  
Nogueira et al. synthesized poly(methyl methacrylate) (PMMA)/ LDH 
nanocomposites by in situ polymerization (Nogueira et al., 2012; Nogueira et al., 2011). 
The LDH was synthesized by co-precipitation varying the divalent/ trivalent 
compositions. Since the LDH’s surface is hydrophilic, it was intercalated by two different 
anions, dodecyl sulfate and lauric acid to enhance hydrophobicity and facilitate 





are (1) an appropriate organic species reduces the hydrophilicity of the clay layers and 
promote compatibility between the layer and the polymer matrix; (2) larger basal spacing 
hinders electrostatic interactions between the layers and makes it easier to achieve 
exfoliation of the layered crystal into single layers. The anion intercalation is important 
because HT presents a small interlayer distance which prevents the intercalation. The 
exfoliation phase of HT was confirmed by XRD results. Thermal degradation 
temperature of nanocomposites was higher than PMMA. The authors explained this 
enhancement as follows: (1) the LDH layers have a much higher thermal resistance than 
organic PMMA molecules, (2) the excellent barrier property of homogeneously dispersed 
LDH single layers prevented the migration of some small volatile molecules from the 
inner matrix to the surface. Other properties of nanocomposites were also improved. 
Elastic modulus tested below the glass transition temperature was increased compared to 
PMMA. The glass transition temperature was also increased due to the decrease in the 
chain mobility; the maximum Tg increase was found to be 17°C. This is supported by 
Marangoni and coworkers who claim that chemical bonding, weak as hydrogen bonding 
or strong as covalent bonding is increasing between the filler and polymer chain when 
intercalated or exfoliated clays are present in the polymer matrix (Marangoni et al., 
2008). Furthermore, the exfoliation of LDH in poly(methyl methacrylate) prepared by in 
situ polymerization results in  enhanced thermal stability caused by the prevention of out-
diffusion of the volatile gas from the thermally decomposing composites. Since 
exfoliated LDH sheets are well-dispersed, they act as a gas barrier, reducing permeability 





PMMA nanocomposites were also investigated by Manzi-Nshuti and coworkers 
(Manzi-Nshuti et al., 2009). PMMA is an optically clear amorphous thermoplastic used 
as a substitute for inorganic glass due to higher impact strength and undergoes ductile 
rather than brittle fracture. The authors incorporated undecenoate-intercalated LDH in 
PMMA by in situ polymerization and obtained exfoliated HT in PMMA. Tg was not 
significantly increased while the molecular weight determined by viscosity measurement 
indicated the increase of molecular weight of the PMMA nanocomposites. The fire-
resistant property was improved since a reduction up to 36% in peak heat release rate 
(PHRR) was found in all PMMA nanocomposites.    
With adequate polymer processing, the desired exfoliation phase can be obtained; 
shear intensity and residence time must be optimized to achieve a high degree of 
exfoliation during extrusion (Dennis et al., 2001).  In addition, the incorporation of 
compatibilizers might be necessary to facilitate the exfoliation.  
 
2.8 Polymer Nanocomposites in Pharmaceutical Applications 
There are very limited studies on polymer nanocomposites in oral solid dosage forms. Ha 
and Xanthos investigated the release characteristics of diclofenac from two carriers (Ha 
and Xanthos, 2011). The first carrier system was obtained by intercalating diclofenac into 
HT to produce a  nanoclay hybrid. Then, the nanoclay hybrid was dispersed in an acrylic 
polymer by melt mixing. The polymer used was Eudragit
®
 E100 (soluble in pH < 5.0) 
and S100 (soluble in pH > 7.0). The intercalation was performed by adding calcined LDH 
in the hydroalcoholic solution containing diclofenac. The solution pH was adjusted to 6.0 





successfully intercalated in its amorphous state in the clay. As a result, the API showed 
increased apparent solubility vs. its crystalline form in simulated gastric fluid (pH 1.2). 
The API release was very rapid in pH 1.2 due to the dissolution of HT in acidic medium. 
The dissolution profile of nanoclay hybrid in simulated intestinal fluid (pH 7.4) showed a 
slower release rate since HT did not dissolve in the neutral pH medium and  the 
intercalated diclofenac anions had to be ion exchanged with the phosphate ions of the 
medium in order to diffuse out from the clay interlayer. The nanoclay hybrid was hot-
melt mixed with Eudragit
® 
in the batch mixer at a given temperature to prepare nanoclay 
hybrid/ Eudragit
® 
composites. The dissolution results in pH 7.4 showed slower release 
than polymer systems that contained only API as a result of an additional diffusional step 
due to the presence of nanoplatelets.  
Some researchers have reported applications in the biomedical field. Chung et al. 
investigated the release of dexamethasone acetate (DexA) from polyurethane 
organosilicate nanocomposites using APIs of different size and polarity (Chung et al., 
2013).  MMT (Closite Na
+
) was modified with organic modifiers before processing with 
polyurethane and API. The nanocomposites containing DexA, a neutral molecule, did not 
dissociate into ions, resulting in unchanged MMT morphology. The API release was 
performed in a sink volume of 50 mL phosphate buffer saline (pH 7.4) placed in a 37°C 
incubator. The presence of clay not only decreased the permeability of the 
nanocomposites due to the impermeable silicate but also the attractive interactions 









3.1.1 Active Pharmaceutical Ingredients 
3.1.1.1 Anionic API: Acetyl salicylic Acid/ aspirin (ASP). ASP was purchased 
from Sigma-Aldrich (St. Louis, USA). It has a melting point of 135°C and its pKa is 3.5 
(25°C). At 25°C, 3 mg of ASP are soluble in 1 ml water while 10 mg of ASP are soluble 
in 1 ml water at 37°C (Sigma-Aldrich). Its structure is shown in Figure 3.1. The solubility 
of ASP in aqueous buffer solutions with pH 1.2 and 7.2 at 25°C is 0.061 mg/ml (Rasool 
et al., 2010) and 2.7 mg/ml (Cayman Chemical, 2012), respectively. ASP is considered as 
anionic API due to the presence of carboxylic group. Therefore, ASP can be intercalated 
into the interlayer of anionic clays. The hydrolysis caused by the breaking of esterified 
functional groups can result in the formation of salicylic acid and acetic acid. Reported 
density is 1.40 g/cm
3
 (Budavari et al., 1996). 
 
 





3.1.1.2 Cationic API: Caffeine (CAF). CAF is purchased from Sigma-Aldrich Co. 
(St.  Louis, USA) and is a white powder with a molecular weight of 194.2 mg/mol. It 
melts in the range of 234-236.5°C (Sigma-Aldrich). CAF’s solubility in water (25°C) is 
16.7 mg/ml, 200 mg/ml at 80°C, and 666 mg/ml in boiling water (Sigma-Aldrich). The 
reported pKa is 14.0 (Lund, 1994) and density is 1.23 g/cm
3
 (Budavari et al., 1996). CAF 
can form salts with acids and is decomposed by strong bases (Clarke and Moffatt, 1986). 
CAF is considered as a cationic API due to the presence of ternary amine groups.  
 
 
Figure 3.2 Chemical structure of CAF. 
 
3.1.2 Polymers 
An anionic copolymer based on methacrylic acid and ethyl acrylate (Eudragit
®
 L100-55) 
shown in Figure 3.3 was kindly provided by Evonik (Piscataway, NJ). Eudragit
®
 L100-
55, with Tg of 110°C is classified as a pH-dependent polymer and is water soluble at pH 
above 5.5 as per supplier’s literature (Evonik Industries, 2011).  The reported density is 
1.21 g/cm
3 
(Yap et al., 2008). The weight average molar mass is approximately 320,000 












The triethyl citrate (TEC) plasticizer shown in Figure 3.4 was purchased from Sigma-
Aldrich (St. Louis, USA). TEC is a colorless and odorless oily liquid with molecular 
weight 276.2 g/mol and density of 1.137 g/mL. Its reported melting point is -55°C and its 
boiling points are 127°C at 1 mm Hg and 294°C at 760 mm Hg. The solubility in water is 












3.1.4.1 Anionic nanoclays: Hydrotalcite.  Hydrotalcite (HT) (Pural
®
 HT 63) is kindly 
donated from SASOL Germany GmbH (Hamburg, Germany). It is a layered double 
hydroxide containing carbonate anions between the layers to neutralize the positive 
charge of divalent (Magnesium) and trivalent (Aluminum) metallic cations forming 
brucite-like layers on the surface (Rives, 2001). The manufacturer’s reported weight ratio 
of Al2O3: MgO is 38:62 and the d-spacing between each layer due to the presence of 
carbonate anions and water is 7.7 Å. The chemical formula is Mg4Al2(OH)12CO3·nH2O 





Figure 3.5  Molecular structure of Pural
®























 was obtained from 
Southern Clay Products Inc. It is a hydrated aluminum silicate with sodium ions kept in 
the interlayer as the predominant exchange cation (Cationic Exchange Capacity = 92.6 
meq/100g). The chemical formula is Na0.33Al2Si4O10(OH)2.nH2O with a d-spacing value 















3.2 Sample Preparation 
3.2.1 Preparation of API/Polymer  
Eudragit
®
 L100-55 was predried in the oven at 70°C for 2 hours to eliminate moisture 
which could promote the hydrolysis of ASP. Eudragit
®
 L100-55 was pre-plasticized with 
TEC in a mortar and pestle. Then, ASP or CAF was added and premixed with the pre-
plasticized polymer until homogeneous powder was obtained. Hot-melt mixed samples 





South Hackensack, NJ). The batch mixer, depicted in Figure 3.7 consists primarily of a 
central bowl section equipped with rotor blades rotating in opposing directions and at 
varying speeds (Martin, 2007). The processing temperature was 100°C with a mixing 
time of 5 minutes at a rotational speed of 50 rpm. After mixing was completed, the 
samples were removed from the mixer and cooled down to room temperature. Thin discs 
were prepared by compressing at 100°C for 1 minute to obtain samples 25 mm in 












3.2.2 Preparation of API/Nanoclay/Polymer Composites 
3.2.2.1 ASP/HT/Eudragit
®
 L100-55. Predried Eudragit
®
 L100-55 was mixed with 
ASP and HT in a mortar and pestle for 5 minutes. Then TEC was added and kneaded 
with the pre-mixed polymer for another 5 minutes until homogeneous powder was 
obtained. Hot-melt mixed samples were prepared in the Brabender FE-2000 batch mixer. 
The processing temperature was 90°C with a predetermined mixing time at a rotational 
speed of 50 rpm. Preliminary runs indicated strong interactions associated with rapidly 
increasing torque, resembling to crosslinking event after a certain mixing time. To 
minimize the torque increase, triplicate runs for each formulation were conducted to 
determine the optimum mixing time as follows: 3 minutes for 5ASP10HT and 
10ASP10HT, and 1 minute for 30ASP10HT.   After the mixing was completed, the 
samples were removed from the mixer and cooled down to room temperature. Thin discs 
were prepared by compressing at 100°C for 1 minute to obtain samples 25 mm in 




 L100-55. The pre-blend preparation of the three 
components was similar to that of ASP/HT/ Eudragit
®
 L100-55. Predried Eudragit
®
 
L100-55 was mixed with CAF and MMT in a mortar and pestle for 5 minutes. Then TEC 
was added and kneaded with the pre-mixed polymer for another 5 minutes until 
homogeneous powder was obtained. The hot-melt mixed samples were prepared in the 
Brabender FE-2000 batch mixer. The processing temperature was 100°C at a rotational 
speed of 50 rpm. The mixing time was 5 minutes since no torque increase was earlier 







55 system.   After mixing was completed, the samples were removed from the mixer and 
cooled down to room temperature. Thin discs were prepared by compressing at 100°C for 
1 minute to obtain samples 25 mm in diameter and 1.0-1.4 mm in thickness for further 
analysis. 
 
3.3 Materials Characterization 
3.3.1 Fourier Transform Infrared (FTIR) Spectrophotometry   
FTIR spectra were obtained using a Spectrum One FTIR Spectrophotometer (Perkin-
Elmer
®
 Instruments, Waltham, MA, USA). KBr pellets containing 1.2-1.5 wt% samples 
were used in the mid-infrared range (400 – 4000 cm
-1
). The normalized % Transmittance 
is plotted vs. wavenumber to represent the FTIR spectra. 
 
3.3.2 Wide-angle X-ray Diffraction (XRD) 
X-ray diffraction spectra were taken with a Philips PW3040 diffractometer (Cu Ka 
radiation, λ= 154 nm), operating at a voltage of 45 kV and current of 40 mA. The 
samples were scanned over the 2 range of 2-70° at the step size of 0.02 and scan rate of 
2.25 s per step. The slit configurations were 0.5°, 0.5°, and 10 mm for divergence, anti-
divergence, and receiving slit, respectively. 
 
3.3.3 Differential Scanning Calorimetry (DSC)   
Measurements of melting point and Tg were carried out by a DSC Q100 (TA Instruments, 
New Castle, DE, USA) under a constant flow of nitrogen at 40 mL/min. Approximately 
5-10 mg samples were weighed and placed in an aluminum pan. Heat rate used in the 





-20°C for 5 minutes and then ramped to 180°C at 2°C/min with a modulation of 0.2°C 
every 40s. The Tg determination was conducted in triplicate and values were measured at 
the midpoint of the transition step of the reverse heat-flow versus temperature curve.   
 
3.3.4 Thermogravimetric Analysis (TGA) 
(TGA) was performed using TGA-7 (Perkin-Elmer
®
 Instruments, Waltham, MA, USA). 
Samples were placed in an open aluminum pan and heated at a rate of 10°C/min in air 





C over 10 minutes for isothermal TGA. All tests were performed in 
duplicate. 
 
3.3.5 Scanning Electron Microscopy (SEM)   
The samples (surface and cross-section) were examined with a LEO 1530 VP Emission 
SEM at 3-5 keV working voltage. After the discs were cooled down to room temperature, 
the cross-section was created by gently bending and breaking the sample with a tweezer 
to minimize the effect on morphology. The samples were coated with carbon using a Bal-
Tee Med 020 Sputter Coater. 
 
3.3.6 Dissolution Test and UV-Vis Analysis   
APIs’ release rate and amounts were investigated by a Distek dissolution system 2100A 
(Distek Inc., North Brunswick, NJ).  Dissolution was studied according to USP 32 using 
apparatus II (paddle) at 37°C ± 0.1°C with a rotational paddle speed of 50 rpm in 
triplicate for both immediate-release and delayed release tests. For immediate release, the 
dissolution medium was 1 L of pH 7.4 phosphate buffer solution representing a simulated 





referred to as acid stage. After 2 hours of operation in the HCl solution, 250 mL of 0.20 
M tribasic sodium phosphate that has been equilibrated at 37°C was added to the vessel. 
The resulting medium’s pH was 7.4±0.1, referred to as buffer stage, and the operation 
was continued. An aliquot of the fluid was withdrawn at predetermined intervals for 
analysis.  
To establish the calibration curve, the ASP standard solution prepared by 
dissolving ASP in the same solvent as in the dissolution test was transferred and diluted 
to obtain the set of calibration solutions ranging in ASP concentration from 20 to 300 
mg/L. The concentration of ASP (calibration solutions and withdrawn samples) was 
measured by UV-vis Spectrophotometer at λmax = 280 nm in the acid stage and λmax = 265 
nm in the buffer stage. For CAF the calibration curve was established similarly to that of  
ASP and the absorbance was measured at λmax = 275 nm in phosphate medium solvent 
(pH 7.4).   The presence of Eudragit
®
 L100-55, TEC, HT and MMT was confirmed in an 
additional study as not interfering with the ASP and CAF absorbance at the selected 
wavelengths. 
 
3.3.7 ASP Quantitative Determination Using High Performance Liquid 
Chromatography (HPLC) 
ASP assay determination followed the USP 32 procedure for aspirin delayed-release 
tablets. The sample discs were cut/ground, and an equivalent amount to 100 mg of ASP 
was weighed and diluted with 20 ml of a diluting solution (mixture of acetonitrile and 
formic acid 99:1) in a 50 ml volumetric flask. The flask was shaken vigorously for about 
10 minutes and centrifuged to prepare a stock solution which was then diluted with the 
diluting solution. An aliquot of diluted stock solution was then injected into a high 





280 nm and C18 column (3.9 mm x 150 mm). Three injections were carried out for each 
sample; the % Assay was the average of 3 injections in which the relative standard 
deviation was < 2.0%. 
 
3.3.8 Rheometry 
Rotational shear rheological characterization was performed using a Rheometrics 
Scientific RMS-800 with plate diameter of 25 mm and gap of 0.8 mm (plate-plate 
configuration). A dynamic frequency sweep was carried out at a strain of 5% within the 
linear viscoelastic region, predetermined by a dynamic strain sweep. The tests were run 







3.3.9 Water Vapor Transmission (WVT) 
The permeability test was followed ASTM Standard Test Methods for Water Vapor 
Transmission (WVT) of Materials (E96-05).  This test evaluates the amount of water that 
is absorbed and permeates through the material being tested. The permeability cup is 
made of stainless steel with 4.80 cm in diameter. The cup was filled with 10 ml of 
distilled water leaving a small gap of air space between specimen and the water. The cup 
was sealed to prevent any vapor loss except through the test sample and then placed on 
the balance. The weight loss was recoded periodically for 7 days in which the cup 
remained on the balance during the entire testing period to avoid an error from the 








3.3.10 Polarized Light Microscopy 
An optical microscope (Carl Zeiss Universal Research Microscope) was used to 











Formulations with various ASP concentrations ranging from 10%-30%w/w are shown in 
Table 4.1. The TEC to Eudragit
®
 L100-55 weight ratio was fixed at 1:4 in all 
formulations. Solubility parameter was used as a tool predicting the miscibility of the 
components of the formulations (Hansen, 2007). Table 4.2 contains values of solubility 
parameters calculated by the authors as per Hildebrand and Hansen equations (Hansen, 
2007) and values taken from published data. The difference of solubility parameters 
among ASP, TEC and Eudragit
®
 L100-55 shown in Table 4.2 is marginal, suggesting a 
miscible plasticized matrix/API system. 
 
Table 4.1 Sample Formulations Prepared by Hot-melt Mixing 









TEC/EUL - 20 80 
API/plasticizer-
polymer 
10ASP 10 18 72 
15ASP 15 17 68 
20ASP 20 16 64 





Table 4.2 Calculated Solubility Parameters (MPa
1/2







Hildebrand  21.4 22.2 21.1 
Hansen 
Hoftyzer/ Van Krevelen* 
23.2 20.9 22.3 
23.1 
Determined from dispersion and 
polar surface free energy** 
24.1   
*  Sauer, 2008 
**Samaha and Naggar, 1991 
 
4.1 Preliminary Study 
Since elevated temperatures are used in hot-melt mixing, thermal analysis was first 
conducted to determine optimum processing parameters; this is crucial for ASPs in which 
the degradation is both dependent on water vapor pressure and temperature (Leeson and 
Mattocks, 1958). Figure 4.1 shows the ASP’s weight loss under dynamic conditions. 
After 150°C, two weight loss steps are shown as follows: (1) release of salicylic acid and 
acetic acid with the formation of an intermediary compound (ASP dimmers) and (2) 
thermal degradation of the intermediary compound (Silva et al., 2004).  Eudragit® 
L100-55 begins to degrade above 150°C due to side chain decomposition (Petereit and 
Weiabrod, 1999; Hughey et al., 2010). An isothermal study was performed in the range 
80-120 °C with 10 minutes of holding time. Approximately 0.2% weight loss was found 
when ASP was heated at the highest temperature used in this study, i.e., 120°C. (data not 
shown). This indicates that in the absence of moisture ASP is stable below 120°C. Figure 
4.2 shows the results of isothermal TGA performed at 110°C. Eudragit
®
 L100-55’s 
weight loss was found to be approximately 3% due to its moisture content, in agreement 
with the weight loss on drying reported in the analysis certificate of the as received batch. 
As a result, Eudragit
®







processing to eliminate moisture which could cause hydrolysis of ASP. Physical mixtures 
of 10ASP and 30ASP showed similar weight losses as the pristine Eudragit
®
 L100-55 
suggesting the absence of any additional adverse interactions among the components of 
the formulations.  
 Given that Eudragit
®
 L100-55 has a Tg of approximately 110°C, TEC has been 
shown to be an effective plasticizer by lowering Tg to approximately 95°C when added at 
10%w/w (Andrews et al., 2008). The 1:4 ratio of TEC:Eudragit
®
 L100-55 employed in 
this work should be able to reduce the Tg by at least 20°C according to published work 
(Ha and Xanthos, 2011; Schilling et at., 2010) . Therefore, the operating temperature in 
the batch mixer was set at 100°C and a 5-minute mixing time was used to minimize the 
degradation of ASP and that of the plasticized polymer.  
To evaluate the uniformity of mixing, the test run was performed on the study 
batch having lowest ASP concentration in this work, i.e., 10%w/w. After processing, five 
samples throughout the batch mixer were examined by DSC and TGA. High consistency 









Figure 4.1 TGA results of (a) ASP, (b) pristine Eudragit
®
 L100-55, (c) TEC. 
 
Figure 4.2 Isothermal TGA at 110°C of (a) ASP, (b) pristine :Eudragit
®
 L100-55, (c) 










































4.2 Mixing Process Monitoring 
Torque and temperature were followed during mixing in order to determine physical or 
chemical state changes. After approximately 45 seconds of fluctuating torque, the torque 
gradually started decreasing, indicating dissolution of the API in the molten polymer as 
shown in Figure 4.3 for 10ASP formulation. As the torque was reaching equilibrium, the 
temperature stabilized at approximately 110°C. No physical and/or chemical changes, 
corresponding to a rapid drop or rapid increase of torque, were evident until the end of 
the mixing cycle which suggests the absence of degradation or structural modification 
under the given mixing conditions 
 








4.3. Determination of % ASP in Polymer Compounds 
The amount of ASP in the melt-mixed samples met USP 32 assay requirements for 
delayed-release tablets (95.0 – 105.0%) as shown in Table 4.3. The limit of free salicylic 
acid according to UPS 32 in the case of tablets that are coated must not be more than 
3.0%. 10ASP showed the highest amount of salicylic acid but still did not fail the USP 
specification. Thus, mixing of an acidic API such as ASP with the acidic Eudragit
®
 L100-
55 does not promote hydrolysis as reported when Eudragit
®
 RL and RS100 were 
employed in formulations containing ASP due to the presence of quaternary ammonium 
groups (Petereit and Weiabrod, 1999). 
 
Table 4.3 Nominal and Actual Amounts of ASP in Melt Processed Formulations 
Formulations %ASP in the  
enteric matrix 
Assay 
%ASP %Salicylic acid 
10ASP 10% 96.3 2.2 
20ASP 20% 97.2 1.8 
30ASP 30% 97.6 1.5 
 
4.4 FTIR Results 
The FTIR spectra in Figure 4.4 show the bands corresponding to ASP, Eudragit
®
 L100-
55, and selected melt-mixed samples. For ASP, the peaks at 1755 cm
-1
 and 1692 cm
-1 
correspond to the C=O vibrations of the ester and the carboxylic acid groups, 
respectively, whereas the peak at 1606 cm
-1
  represents C=C in the benzene ring. The 
broad band in the range of 2500 – 3200 cm
-1
 is due to the OH vibrations of the carboxylic 
group (Rasool et al., 2010; Ajun et al., 2009; Olmsted III, 1998). Eudragit
®
 L100-55 











. Additional  ester vibration peaks are found at 1269 and 1179 cm
-1
.  The peaks 
at 1396, 1449, and 1475 cm
-1
 correspond to CHx vibrations as per Evonik’s literature. 
For TEC/EUL, 20ASP and 30ASP formulations, there is an overlap of the -OH 
vibrations associated with the carboxylic group (2500 - 3300 cm
-1
) and alcohol (2700 – 
3500 cm
-1
), resulting in a very broad range 2500 – 3500 cm
-1
. Additional evidence 
suggesting that no significant changes occurred to the samples processed by hot-melt 
mixing is the presence of the original bands representing esterified carboxylic group at 
1753 cm
-1
 as shown in Figure 4.4 (e) – 20ASP and Figure 4.4 (f) – 30ASP. These peaks 
cannot be detected in Formulations 10ASP and 15ASP, possibly because of the low ASP 
concentration. However, a new intense peak is observed at 1400 cm
-1
 in all processed 
formulations. TEC/EUL sample, containing only TEC and Eudragit
®
 L100-55 also shows 
this strong peak at 1401 cm
-1
.This peak probably corresponds to the shift of the CHx 












Figure 4.4 FTIR spectra of (a) ASP, (b) pristine Eudragit
®
 L100-55, (c) TEC, (d) 
TEC/EUL, (e) 20ASP, (f) 30ASP. 
 
4.5 XRD Results 
XRD was used to investigate the state of ASP in the hot-melt mixed samples and the 
possible formation of salicylic acid during melt-mixing. ASP shows a number of sharp 
peaks, suggesting a highly crystalline structure (Figure 4.5). The two main characteristic 
XRD peaks of ASP are displayed at 2 of 7.8° and 15.6° with the latter 2 angle having 
apparently a greater intensity. These two distinct peaks are found in all processed samples 
even at the lowest ASP concentration of 10% (10ASP) whilst 30ASP showed most of the 
corresponding ASP’s XRD peaks due to the high ASP loading. The crystal structure was 































temperature; by contrast, Eudragit
®
 L100-55, an amorphous polymer, and its plasticized 
version (TEC/EUL) do not show any peaks. This indicates that ASP is immiscible with 
the plasticized polymer, and therefore not molecularly dispersed at room temperature. 
Unlike ASP, the XRD spectra of salicylic acid, a derivative of ASP, taken from the 
literature (Turk and Lietzow, 2008; Fukuoka et al., 1987) have two nearly equal intensity 
peaks at 2of 11.0° and 15.6° which do not appear in the melt-mixed samples. 
 
 
Figure 4.5 XRD spectra of (a) ASP, (b) pristine Eudragit
®
 L100-55, (c) TEC/EUL, (d) 






























4.6. Glass Transition Temperature (Tg) Determination 
To evaluate the effect of API on the polymer Tg, thermal analysis data of the processed 
samples and the physical mixtures of identical ASP-TEC/Eudragit
®
 L100-55 
formulations are shown in Figure 4.6. Pristine Eudragit
®
 L100-55’s Tg was determined to 
be 122°C which is in agreement with Evonik’s specifications. At a 1:4 ratio of 
TEC:Eudragit
®
 L100-55, Tg was reduced by 20°C to 100.5°C. By adding ASP in the 
polymer matrix, Tg decreases with increasing ASP loading from 0% to 30%, in both 
physical mixtures and melt mixed samples; this shows the additional plasticizing effect of 









































4.7 Dissolution Tests 
The controlled release of ASP from the polymer compounds prepared by hot-melt mixing 
is shown in Figure 4.7 and Figure 4.9 for immediate-release (pH 7.4) and delayed-
release, respectively. The purpose of conducting immediate-release dissolution is two-
fold: (1) to examine the difference in the dissolution profiles with and without an acidic 
stage and (2) to investigate  the API release mechanism by curve fitting with modeling 
equations since the sample is tested under one condition and 100% of API is still present 
in the sample at time = 0. Note that the API at the surface might be released in the acidic 
stage, resulting in <100% of API in the sample as the medium’s pH is raised to that of the 
buffer stage. Figure 4.7 shows no significant differences of the ASP release profile 
among three concentrations in the pH 7.4 medium. In 10ASP, the API was steadily 
released from the matrix and reached the maximum concentration over a period of 5 
hours.  Slightly faster release rates were found in 20ASP and 30ASP resulting in 
complete release within 4 hours. In 30ASP, the initial burst effect is presumably caused 
by undissolved ASP in Eudragit
®
 L100-55 at the disc’s surface since the ASP loading 









Figure 4.7  Immediate-release dissolution profiles (pH 7.4) of (●) ASP, (◊) 10ASP, (□) 
20ASP, (∆) 30ASP. 
 
A water-soluble API incorporated in a polymer matrix is mainly released by 
diffusion, while self-erosion dominates in a low water solubility API (Costa and Lobo, 
2001). Eudragit
®
 L100-55 is an erodible pH-dependent solubility polymer which is 
intended to dissolve in neutral to weakly alkali conditions (Al-Taani and Tashtoush, 
2003). Since ASP is a water-soluble API with a pKa 3.5 it is highly soluble in the pH 7.4 
medium as depicted in Figure 4.7. Hence, it can be anticipated that the release 
mechanism of ASP-plasticized Eudragit
®
 L100-55 should be drug diffusion dominating. 
To investigate the mechanism controlling the release of ASP, statistical analysis and 
modeling equations can be used. Power law is a simple equation (4.1) describing solute 


























Fickian), Case-II transport and Super-Case-II transport (Peppas and Sahlin, 1989; Ritger 




     
(4.1) 
      
  
  
 is the ratio of the mass of drug released at time t to the mass of drug released at time 
approaching infinity, k is a constant incorporating characteristics of the macromolecular 
network system and the drug, and n is the diffusional exponent, which is indicative of the 
transport mechanism. The sample geometry has an effect on the diffusional exponent n. 
The aspect ratio 2a/L, where a is the sample’s radius and L is the thickness, is used to 
define the geometry. The aspect ratio of the samples in this work is approximately 25 and 
is, thus, assumed to be the case of a thin film. For such a case, Fickian diffusion is 
determined by n = 0.5, non-Fickian (Anomalous) by 0.5 < n < 1.0, Case-II transport by n 
= 1.0 and Super-Case-II transport by n >1.0.   For Fickian diffusion (n=0.5), k can be 
defined as: 
 
    
 
   




The data shown in Table 4.4 are calculated by using curve fitting tool in 
MATLAB
®
 version R2011b with 95% confidence interval (CI). R
2
 is greater than 0.99 







caused by the burst effect. Transport mechanisms for all formulations followed non-
Fickian transport since 0.5 < n < 1.0. At low ASP concentration, the n value of 0.86 is 
close to that of case II transport associated with polymer relaxation, while at ASP 
loadings up to 30% the n value of 0.59 is close to 0.5, associated with diffusion 
contribution. Thus, the drug diffusion mechanism predicted earlier for this system should 
be valid when the ASP loading is higher than 30%w/w.  
 












 + k2t 








10ASP 0.86 ± 0.06 1.18 ± 0.44 0.43 ± 0.05 
20ASP 0.78 ± 0.08 1.97 ± 0.63 0.36 ± 0.07 
30ASP 0.59 ± 0.15 3.78 ± 1.66 0.18 ± 0.22 
1
 Ritger and Peppas, 1987 
2
 Peppas and Sahlin, 1989 
 
Another equation, Equation (4.3), can be used to differentiate the diffusion and 




           
(4.3) 
 
The first term on the right-hand side represents the Fickian diffusion contribution 
of the API; the second term is responsible for the relaxational contribution (erosion) of 
the polymer. The purely Fickian diffusional exponent (m) for different shapes has been 







0.5.  Equation (4.1) and (4.3) are valid for the first 60% of the fraction release (Mt/M∞ ≤ 
0.6). The data from curve fitting are shown in Table 4.4.  
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The percentage of API release due to Fickian mechanism (F) is calculated as 
     









With a coupled diffusion/relaxation model for the polymer matrix containing ASP 
it is shown that diffusion contribution was dominant since the k1 value was greater than k2 
in all cases. However, the plot of F vs. time according to Equation (4.5) revealed 
explicitly the degree of API diffusion over time as displayed on Figure 4.8. 30ASP has 
the highest F among other formulations and its value gradually dropped to roughly 0.5 at 
the end the test while the F of 10ASP and 20ASP decreased rapidly at the beginning and 
reached equilibrium at a value below 0.25. It is interesting that the dissolution profile 







the degree of diffusion was dramatically different. The amount of ASP has an impact on 
the ratio of diffusion to relaxation contribution at a given time.  
 
 





 L100-55 is normally used as enteric coating material, the 
delayed-release profile was investigated to ensure that the polymer matrix can withstand 
the acidic stage for 2 hours and can maintain a sustained release profile by slowly 
releasing ASP after the medium is adjusted to a buffer stage. Figure 4.9 shows the 
delayed-release profile of formulations 10ASP and 30ASP. According to USP 32 (2009)-
section 711-, under delayed-release dosage forms dissolution, no individual sample 
exceeds 10% release when dissolved in the acid stage. In fact, in the acidic stage (2 
hours), 7.4% and 8.8% of ASP were released from 10ASP and 30ASP, respectively. 



































the samples processed by HME deliver a lower porosity matrix (Schilling et al., 2010).  
After the pH was raised to 7.4, sustained release profile was obtained and achieved 
maximum concentrations at periods similar to those occurring in immediate-release 
dissolutions (pH 7.4). In both formulations, the release in the buffer stage of the delayed-
release was enhanced to some extent due to the fact that the samples were submerged in 
acidic solution earlier for 2 hours leading to the access of the medium to the enteric 
matrix. Once the pH was increased to 7.4, the formed porous network during the acid 
stage promoted ASP release. 
 
 
Figure 4.9 Delayed-release dissolution profiles of (◊) 10ASP, (∆) 30ASP. 
 
The enteric dosage form with prolonged-release in the small intestine obtained by 
hot-melt mixing in this study could benefit patients as follows: First, if the API is 



























enteric dosage form; this form could also prevent the API to be released in the stomach if 
it causes stomach irritation. Second, the food residence time in the small intestine 
(duodenum, jejunum and ileum) is approximately 4-6 hours (Allen et al., 2011).  
Providing a prolonged release, this would allow the API to be slowly released during  the 
residence time and,  therefore, the intake frequency could be reduced.   
 
4.8 Rheology Results 
Figure 4.10 shows shear viscosity vs. frequency curves for the five formulations 
measured at 100°C. The viscosity of the samples decreased with increasing ASP 
concentration and also with increasing frequency. It was also noted that samples 
containing ASP appeared to be less brittle than TEC/EUL samples. The curves for 10ASP 
and 15ASP showed little differences presumably as a result of the small differences in 
ASP concentrations. However, the curves for formulations 20ASP and 30ASP are nearly 
identical. This may be related to the fact that ASP loading at 20-30% is approaching the 
limit of its solubility in Eudragit
®









Figure 4.10  Viscosity vs. frequency curves measured at 100°C of (O) TEC/EUL, (◊) 
10ASP, (+) 15ASP, (□) 20ASP, (∆) 30ASP. 
 
The viscosity data are plotted as viscosity ratios of compound/matrix (o) vs. 
%ASP in Figure 4.11. It appears that the ratio starts increasing at some concentrations 
above 20% in agreement with the interpretation of the data in Figure 4.10 that suggest 
transition from ASP solution to ASP dispersion at ASP concentrations approaching 20%. 
The present data are in good agreement with those of the rheological method employed 

























Figure 4.11  Viscosity ratio at different ASP concentrations and different frequencies 
measured at 100°C. 
 
Oscillatory experiments provide information on the storage (elastic) component 
(G') and loss (viscous) component (G'') of the modulus for a given system at a given 
temperature. Figure 4.12 shows a plot of G' vs. G'' (modified Cole-Cole plot) with 
interception line and a crossover point. G' = G'' for all five formulations. Most points of 
TEC/EUL fall above the line and this corresponds to a predominant elastic response. In 
the presence of ASP, the rheological properties are altered and are a function of 
frequency. Crossover points were found at 0.55, 0.94, 2.27, and 4.92 rad/s for 10ASP, 
15ASP, 20ASP, and 30ASP, respectively; in other words more points were obtained 
under the interception line at greater ASP loadings. This clearly shows a more viscous 








































Figure 4.12 Plot of storage modulus (G') vs. loss modulus (G'') of (O) TEC/EUL, (◊) 
10ASP, (+) 15ASP, (□) 20ASP, (∆) 30ASP. The solid line represents the case of G' = G''. 
 
4.9 SEM Results 
Figure 4.13 - 4.16 show pristine ASP crystals and cross-sections of melt-mixed samples.  
After the melt-mixed samples were pressed and cooled down to room temperature, the 
discs were dissected and observed immediately. ASP (Figure 4.13) showed oblong-
shaped crystals with size ranging from 400 - 1000 µm. ASP crystals were carbon-coated 
twice due to excessive charging while cross-sectional samples had normally a single-
layered coating observed as bright spots in the images. TEC/EUL (a plasticized polymer) 
has a smooth surface. Crystals of ASP were found as bright spots in Figure 4.15 and 4.16 





























agreement with XRD spectra suggesting that recrystallized ASP crystals were present 
even at the low concentration of 10%ASP.   
 
Figure 4.13  SEM of ASP crystals. 
 









Figure 4.15  SEM of cross-section of 10ASP. 
 














L100-55 formulations are shown in Table 
5.1. HT was added at a concentration of 10%w/w in all polymer nanocomposite 
formulations. Reported AEC of HT is 3.4 meq/g (Toraishi et al., 2002); the maximum 
amount of ASP which can be exchanged with original anions in HT is 6.13 g per 10 g of 
HT (see Appendix A). The amount of ASP in the formulations was varied from below 
AEC to above AEC values of HT. 
 
Table 5.1 Sample Formulations Prepared by Hot Melt Mixing 
 
System Formulation  Component (%wt) 






10HT - 10 18 72 
      
API-nanoclay- 
plasticizer-polymer 
5ASP10HT 5 10 17 68 
10ASP10HT 10 10 16 64 
30ASP10HT 30 10 12 48 
 
 
                   5.1 Mixing Process Monitoring 
The evolution of torque of sample 10HT during mixing in the batch mixer is shown in 
Figure 5.1. In the first minute, the torque value increased and remained steady afterwards. 
The torque did not decrease as previously observed in the ASP/Eudragit
®
 L100-55 
samples since HT is not dissolved in the molten Eudragit
®








Figure 5.1 The evolution of torque of 10HT during melt mixing. 
 
Systems containing ASP, HT and Eudragit
®
 L100-55 showed, however, a 
different behavior that was attributed to the presence of strong interactions or occurrence 
of reactions among the components after a certain period of mixing time. Preliminary 
runs for all three ASP/HT formulations showed a similar pattern of torque evolution. 
After the pre-mixed components were fed into the chamber, the torque dramatically rose, 
followed by a gradual decrease since ASP was dissolved in the molten polymer while HT 
remained instead in suspension. At this phase, the mixture was in a rubbery state. As 
mixing proceeded further, the torque (and the corresponding viscosity) increased again as 
a result of a possible crosslinking reaction and declined towards the end of the run when a 
dry and bulky powder reminiscent of crosslinked polymer was formed. Three preliminary 


























place repeatedly in the same manner and at the same time and torque levels. Hence, the 
onset of the torque increase was used as an endpoint of optimum mixing time in the 
actual runs of all formulations.  
During melt mixing, the increase in torque indicating a strong interaction between 
carboxylic groups of the polymer and Al and/or Mg of the HT has been reported by 
Pradhan and coworkers (Pradhan et al., 2008). The HT was intercalated with anionic 
surfactant sodium 1-decanesulfonate in order to enhance its hydrophobic property and 
expand the HT’s basal space, resulting in an ease of polymer chain intercalation. In this 
dissertation, both ASP and Eudragit
®
 L100-55 contain carboxylic groups which can 
interact with Al and/or Mg in HT. Therefore, it is possible that the initial portion of 
decreased torque is due to the dissolution of ASP in the polymer melt and promotion of 
the intercalation in the HT layers. Then, the HT layers can be sufficiently separated in 
order to accommodate large species such as carboxylic group bearing polymer chains. A 
complex between HT and carboxylic groups from both ASP and Eudragit
®
 L100-55 can 
then be obtained. 
The mixing times for 5ASP10HT and 10ASP10HT prior to the torque increase, 
shown in Figures 5.2 and 5.3, respectively were determined to be approximately 3 
minutes. Product appearance and torque evolution were closely monitored during mixing 
to ensure that the possible crosslinking reaction was not yet initiated. For the 
30ASP10HT sample (Figure 5.4), the onset of the torque increase occurred after only 80 
seconds in the preliminary run. It is also of interest that the torque level before and after 
the onset of the torque increase is lower than that in the 5ASP10HT and 10ASP10HT 







30ASP10HT system was set at 60 seconds. These results confirm that ASP is a critical 
reactant whose concentration dictates the rate and extent of the possible crosslinking 
reaction. It should be noted that the majority of melt mixed samples were further heated 
at 100
o
C for about a minute to produce films suitable for subsequent characterization by 
FTIR, XRD and other methods. Thus, it is highly likely that in these samples the reaction 
responsible for the torque increase has indeed taken place. 
The possibility of a crosslinking reaction is discussed further in this dissertation 
(Sections 5.3 and 5.6) as a reaction that gives rise to aluminum and/or magnesium 
carboxylate salts derived from the carboxylic groups of aspirin and the multiple sites  of 
metal oxides/hydroxides present in the HT. 
 




























Figure 5.3 The evolution of torque of sample 10ASP10HT during melt mixing. 
 
Figure 5.4 The evolution of torque of sample 30ASP10HT during melt mixing. 
 
5.2 XRD Results 
Figure 5.5 shows XRD spectra of Eudragit
®
 L100-55, HT and 10HT. Eudragit
®
 L100-55 
is an amorphous polymer and, therefore, does not show any peaks. Since HT has a 
double-layered metal hydroxide structure consisting of magnesium and aluminum 




















































, representing d001 and 
d002 planes, respectively. According to Bragg’s law of diffraction, the corresponding 
basal spacing of HT at the first angle is 7.8 Å which is in agreement with the supplier’s 
specifications and other authors data (Arco et al., 2007; Crepaldi et al., 2002; Ambrogi et 
al., 2001). In general, the basal spacing is measured from the bottom to bottom of the two 
brucite layers which contain intercalated anions (Figure 3.5). The reported thickness of 
the brucite layer is 4.8 Å (Nalawade et al., 2009; Drezdzon, 1988) while the diameter of 
the intercalated CO3
2- 
is 3 Å (Crespo et al., 1997); therefore, the resultant basal spacing is 
7.8 Å.   The high intensity peaks at the HT’s original 2 angle in the spectrum of 10HT 
suggest an intact double-layered structure. This also implies that the carbonate anions 
trapped within the HT’s interlayer are not replaced by the polymer chains or, in other 
words, no intercalation of HT by the Eudragit
®
 L100-55 chains containing methacrylic 









Figure 5.5  XRD spectra of (a) Eudragit
®
 L100-55, (b) HT, (c) 10HT. 
 
 
ASP and HT have highly ordered crystalline structures, with XRD peaks shown in 
Figures 5.6 (a) and (b), respectively. It appears that hot melt mixing of ASP with the 
Eudragit
®
 L100-55 polymer matrix containing HT enhanced the collapse of HT’s double-
layer structure resulting in partial intercalation and exfoliation.  For the sample with the 
lowest ASP concentration, 5ASP10HT (Figure 5.6 (c)), the d001 plane was shifted from 
the 2 angle of 11.6° to 4.9° indicating an increase of basal spacing from 7.7 Å to 17.9 Å. 
The increased basal spacing could be due to the intercalation of both ASP molecules and 
Eudragit
®
 L100-55 polymer chains. The new corresponding spacing between the two 
brucite layers was 13.1 Å (after subtracting 4.8 Å from 17.9 Å). ASP’s molecular size has 
been determined by several researchers. ASP’s dimensions reported by Hong and Wen-
gong are 8.1Å x 7.2Å x 3.6Å (Hong and Wen-gong, 2010) whereas Xu and coworkers 





















suggested a different largest dimension of ASP of 7.27Å (Xu et al., 1999). Since the 
expanded basal spacing of the 5ASP10HT composites is larger than the dimension of 
ASP, the increased basal spacing was possibly responsible for the ASP molecules 
intercalated into the HT interlayer by replacing the original carbonate anions. The 
increased basal space caused by the polymer chain is varied based on polymer structure 
and the basal space is expanded by approximately 10 Å - 20 Å (Ardanuy et al., 2010; 
Fornes, et al., 2002; Giannelis et al., 1999). 
The intercalation of ASP into the LDH layers has been successfully performed 
under different processing conditions. Hong and Wen-gong intercalated ASP in a 
MgAlZn layered-double hydroxide by co-precipitation using ZnCl2 and MgCl2 as 
precursors (Hong and Wen-gong, 2010).  In general, carbonate anions entrapped in the 
layered-double hydroxide are difficult to be replaced by ion exchange. One method to 
remove carbonate anions is calcination by heating pristine LDH up to approximately 300-
500°C for several hours (Ha and Xanthos, 2011; Constantino et al., 2008; Crepaldi et al., 
2002). The present study suggests that intercalation can occur rapidly by high shear at 
elevated temperatures during HMM in the batch mixer within 3 minutes (optimum 
mixing time for 5ASP10HT). However, the HT’s characteristic XRD peaks can still be 
observed at 11.6° and 23.3°, albeit at lower intensity as compared to pristine HT. This 
indicates that there is still HT remaining in agglomerated form which has not intercalated 
ASP molecules yet. For 10ASP10HT, a similar XRD spectrum is observed in Figure 5.6 
(d). However, the lower intensity of the HT peaks at 2 of 11.6° and 23.3° suggests its 
partial exfoliation. Therefore, two states of HT, namely an intercalated and an exfoliated 







the double-layer structure, and a less ordered arrangement which can be observed in the 
30ASP10HT sample. The two characteristic peaks of HT completely disappear (Figure 
5.6 (e)), suggesting an exfoliation state of the HT due to the collapse/separation of the 
layer structure to multiple platelets. There is no intercalation peak at a lower angle 
anymore; instead, crystalline peaks of ASP are present. 
 
 
































5.3 FTIR Results 
Figure 5.7 includes FTIR spectra of pristine Eudragit
®
 L100-55, HT, TEC/ Eudragit
®
 
L100-55 and 10HT. Eudragit
®
 L100-55 contains ester and carboxylic functional groups 
which correspond to the peaks at 1736 cm
-1
 and 1705 cm
-1 
due to the C=O vibrations of 
the esterified carboxylic group and carboxylic acid group, respectively. Additional ester 




.  The peaks at 1396, 1449, and 
1475 cm
-1
 are responsible for CHx vibrations as per Evonik’s literature. HT shows intense 




 which are correlated with the -OH 
stretching modes of free and hydrogen-bonded hydroxyl groups in the hydroxide layer 
and interlayered water (Choy et al., 2004; Hernandez-Moreno et al., 1985). The band 
below 700 cm
-1
 is due to Mg/Al-OH stretching mode in the brucite-type layers (Arco et 
al., 2007; Aisawa et al., 2001; Pavia et al., 2009). The entrapped carbonate anions in 
HT’s interlayer spacing correspond to a band at 1371 cm
−1
 due to asymmetric stretching 
of C=O (Ha and Xanthos, 2011; Kang et al., 2005). TEC/ Eudragit
®
 L100-55, the 
processed polymer sample with only TEC, revealed a new intense sharp peak at 1401  
cm
-1
 shifted from CHx vibrations at 1396 cm
-1
. The C=O vibration of the esterified 
carboxylic group still remained at 1735 cm
-1
 but with lower intensity. For the 10HT 
sample, the asymmetric stretching C=O band of the intercalated carbonate anions was 
superimposed by the CHx vibrations of Eudragit
®
 L100-55 peak at 1400 cm
-1
 whilst the   
-OH stretching modes of free and hydrogen-bonded hydroxyl group in the hydroxide 
layer and interlayered water are still found at 3000-3500 cm
-1











Figure 5.7 FTIR spectra of (a) Eudragit
®
 L100-55, (b) HT, (c) TEC/EUL, (d) 10HT. 
 
The FTIR spectra for ASP and the polymer nanocomposites are displayed in 
Figure 5.8 (400-4000 cm
-1
) and Figure 5.9 (600-2000 cm
-1
). For ASP, the peaks at 1755 
cm
-1
 and 1692 cm
-1 
correspond to the C=O vibrations of the ester and the carboxylic acid 
groups, respectively, whereas the peak at 1606 cm
-1
 represents C=C in the benzene ring. 
The broad band in the range of 2500-3200 cm
-1
 is due to the OH vibrations of the 
carboxylic group (Rasool et al., 2010; Ajun et al., 2009; Olmsted III, 1998). All spectra 
of the polymer nanocomposites are dominated by -OH stretching at around 3500 cm
-1
 
with the intense peak at 1400 cm
-1
 correlating with CHx vibrations. Broad peaks observed 
at 1736 cm
-1
 in 5ASP10HT (Figure 5.9 (b)) are merged ester and carboxylic group peaks. 
































of ester group) and 1692 cm
-1
 (C=O) of carboxylic group), respectively. This is evidence 
that ASP did not undergo hydrolysis during HMM.  
Interestingly, there is a new peak of carboxylic acid salt shown at 1585 cm
-1
 in 
10ASP10HT as illustrated in Figure 5.9 (c). It is attributed to the asymmetric carbonyl 
stretching vibration of carboxylic acid salt (-COO
-
) (Socrates, 2001) or, more specifically 
to the magnesium carboxylate salt (Laskowska and Lipinska, 2012). Laskowska and 
Lipinska reported that absorption band of asymmetric carbonyl stretching of magnesium 
carboxylate salt at 1587 cm
-1
. The presence of COO
-
 peaks in this region was also 
reported in ibuprofen-intercalated HT and mefenamic-intercalated HT (Arco et al., 2007; 
Ambrogi et al., 2001). Another absorption band is observed at 1025 cm
-1
 which is 
responsible to the Al-O-C group (Tunney and Detelier, 1994). 
 
According to the XRD 
results of 10ASP10HT, either ASP molecules or Eudragit
®
 L100-55 polymer chains or 
both are intercalated into the HT layer. In the case of polymer chain-intercalated HT, the 
carboxylic groups of Eudragit
®
 L100-55 are bonded to HT through Al-O-C bonding 
(1025 cm
-1
) and Mg-O-C bonding (1585 cm
-1
).  For ASP molecules, the intercalation 
takes place through the similar Al-O-C and Mg-O-C bonding, resulting in the Al/Mg salt 
form of ASP. These two peaks (Al-O-C and Mg-O-C) should have also been present in 
5ASP10HT (intercalated ASP); they did not, however, probably due to the lower ASP 
concentration. According to the FTIR spectra of 10ASP10HT, both carboxylic acid group 
(1692 cm
-1
) and carboxylic acid salt (1585 and 1025 cm
-1
) of ASP are present. This 
implies that there were 2 forms of ASP in the 10ASP10HT sample, i.e. free ASP and 
intercalated ASP. Based on the anionic exchange capacity of HT, the maximum amount 







with the presence of intercalated and free ASP forms in 10ASP10HT as the FTIR spectra 
suggest. Unfortunately, the amounts of each ASP species cannot be quantified by FTIR 
spectroscopy.  
The 30ASP10HT spectrum depicted in Figure 5.9 (d) also shows the band at 1024 
cm
-1
 (Al-O-C) as observed in 10ASP10HT. However, the COO
-
 peak of 30ASP10HT is 
found at 1621 cm
-1
 vs. 1585 cm
-1
 for 10ASP10HT (The nearby peak located at 1606 cm
-1
 
is corresponding to C=C of ASP’s benzene ring). Carboxylic acid salts have a strong, 
characteristic band in the region 1540-1695 cm
-1
 due to the asymmetric stretching 
vibration of COO
-
 (Socrates, 2001) which depends on both the metal ion (Al and Mg in 
our case) and the organic portion of the salt. Other researchers suggested the band at 
1612-1615 cm
-1
 corresponds to the carbonyl stretching vibrations of magnesium 
hydroxycarboxylate salt (Mandal, 2000; O’Keefe, 2004). It is inconclusive which 
element (Al or Mg) is responsible for the band at 1621 cm
-1
 for 30ASP10HT. 
30ASP10HT’s XRD spectrum suggests the exfoliation of HT. Therefore, this band at 
1621 cm
-1
 is presumably due to the bonding between carboxylic group of ASP and/or 
Eudragit
®
 L100-55 to either Mg or Al of HT. Since the 30ASP10HT spectrum also shows 
the peak of the ASP carboxylic group (1692 cm
-1
), then, 30ASP10HT contains two forms 
of ASP, i.e. free ASP and bonded-ASP molecules with HT platelets. 
Note that, Aluminum ASP (ASP-Al) and Magnesium ASP (ASP-Mg) are 
available in several forms. Mitra and Pitkin registered a patent for the production in the 
form of mono-hydroxy aluminum di-acetylsalicylate (Mitra and Pitkin, 1960). Aluminum 
ASP in which three anions of ASP are bonded to one Al cation (molecular formula: 







Book, 2010).  Magnesium aspirin (magnespirin) in which a magnesium cation is bonded 
to two anions of ASP is also available (PubChem). Table 5.2 summarizes the morphology 
of HT and ASP forms according to XRD and FTIR results. 
 
 



























Figure 5.9 FTIR spectra (600-2000 cm
-1


















































Table 5.2 Summary of HT Morphology and ASP Forms in the Polymer Nanocomposites 
Sample Form of ASP and 
HT 
XRD FTIR 
10HT Agglomerated HT  d001 = 11.6°  C=O band of CO3
2-
 
intercalated in HT was 




L100-55 peak at 1400 cm
-1
 
    
5ASP10HT Agglomerated HT  d001 = 11.6° C=O band of CO3
2-
 
intercalated in HT was 










 d001 = 4.9° Cannot be detected 




 d001 = 4.9° Carboxylic acid salt (Mg-O-
C at 1585 cm
-1




 Partial exfoliated 
HT 
 
Lower intensity of d001 at 
11.6° and 23.3° 
Cannot be detected 
 Free ASP Cannot be detected  Carboxylic acid (1692 cm
-1
) 
and ester (1753 cm
-1
) 
30ASP10HT Bonded-ASP with 
exfoliated HT 
 
Disappearance of d001 at 
11.6° and 23.3° 
Carboxylic acid salt (1621 
cm
-1
 and Al-O-C (1024 cm
-1
) 
 Free ASP Characteristic ASP 
peaks shown 
Carboxylic acid (1692 cm
-1
) 




5.4 Glass Transition Temperature (Tg) Determination 
Tg is an important property in polymer processing since it represents the transition 
temperature from glassy to rubbery state. Measured Tg values are shown in Figure 5.10. 
Pristine Eudragit
®
 L100-55’s Tg is determined to be 122°C, in agreement with Evonik’s 
specifications. At a 1:4 ratio of TEC:Eudragit
®
 L100-55, Tg is  reduced by 20°C to 
100.5°C. 10HT shows a slightly increased Tg by approximately 5°C since the 
agglomeration of HT has limited the free volume of the polymer chains, causing 







exfoliated HT can increase Tg due to H-bonding and covalent bonding of the well 
dispersed filler and polymer chain (Nogueira et al., 2011). By adding ASP in the 
HT/Eudragit
®
 L100-55 polymer matrix, Tg decreased with increasing ASP loading from 
5% to 30%. The plasticizing effect of ASP to the TEC containing polymer by lowering Tg 
to 91.6°C at 30%w/w of ASP was shown in Chapter 4. Although nanocomposites with 
intercalated (10ASP10HT) and exfoliated (30ASP10HT) states of HT are obtained by 
HMM, the plasticizing effect of ASP still dominates by reducing the Tg. Note that 
processed 10ASP10HT has the highest standard error, possibly due to the presence of the 









































5.5 SEM Results 
Figure 5.11 shows ASP’s oblong-shaped crystals with size ranging from 400 - 1000 µm. 
The ASP crystals were carbon-coated twice before conducting SEM due to their high 
charge, resulting in bright spots in the image. Pristine HT is shown in Figure 5.12 at two 
magnifications. A single platelet with approximately 150-300 nm in length can be 
observed in Figure 5.12 (a) whist various sizes of agglomeration formed by multiple 
platelets of HT with sizes up to 50 m are shown in Figure 5.12 (b). The cross section of 
sample discs was examined in order to confirm different morphological features of HT as 
suggested by the XRD results. At the magnification of 500x (Figure 5.13 (b)), 
5ASP10HT shows random sizes of HT ranging between 25–200 m. The bright spots are 
presumably ASP molecules because the nanocomposite samples were carbon-coated 
once. EDX mapping of C and Mg atoms is illustrated in Figure 5.14. The size of HT 
sheets becomes smaller (25-100 m) and more uniform  as the ASP concentration is 
raised to 10%w/w as shown in Figure 5.15. Adding more ASP promoted the delamination 
of the HT agglomerates. The cross-sectional texture of the 30ASP10HT sample (Figure 
5.16) is remarkably dissimilar from those of the 5ASP10HT and 10ASP10HT samples. 
The texture suggests the formation of a percolating network of ASP and HT platelets. 
EDX mapping in Figure 5.17 shows the distribution of Mg atoms (and that of HT 



































Figure 5.12 SEM of HT (a) single platelet (courtesy of Dr. T.G. Gopakumar, Polymer 


















































































Figure 5.17 EDX Mg mapping of Figure 5.16 (b). 
 
5.6 Dissolution Tests 
The polymer nanocomposites containing 10% w/w of HT and various ASP concentrations 
showed a controlled-release ASP profile in the immediate-release tests in pH 7.4 medium; 
the extent of release inhibition strongly depends on the ASP concentration. The 
immediate-release test was performed in order to compare the ASP release profile with 
that of the delayed release, which involves two hours exposure in acidic conditions before 
returning to the pH 7.4 medium.  In addition, the API release analysis using mathematical 
models is facilitated since the sample is tested under one pH condition and 100% of the 
API is still present in the sample at time t= 0. Figure 5.18 shows the dissolution profiles of 
the three nanocomposite formulations and that of ASP powder under the immediate 
release conditions of pH 7.4. For the 5ASP10HT sample, the ASP concentration reached 
approximately 95% over a period of six hours. The dissolution rate of 5ASP10HT is 
slightly slower compared to the ASP/Eudragit
®







in which 95% ASP release was reached over a period of four hours in all three 
formulations containing 10%-30% ASP. The release of ASP is retarded due to two 
reasons: Firstly, the presence of ASP intercalated HT slightly increases the nanocomposite 
tortuosity, resulting in longer time for the medium to reach the ASP However, according 
to SEM microphotographs, this effect may not be significant since the cross-section of 
5ASP10HT at this HT concentration still shows a limited distribution of HT particles. The 
second mechanism which mainly contributes to the slower release of ASP is the 
intercalation of ASP into HT. Ion exchange between the phosphate ions in the pH 7.4 
medium and the intercalated ASP must occur; then the ASP molecule is released from the 
HT and dissolves in the medium.   
Remarkably, increasing the ASP concentration to 10% and 30% changes the 
ASP’s release rate to about 90% over a 24 hours period and about 65% over a 48 hours 
period, respectively. Technically, prolonged-release as in this case is unnecessary for oral 
dosage forms due to the fact that the total gastrointestinal residence time is approximately 
4-8 hours; it could be suitable, however, for implant or transdermal patch dosage forms 
requiring long term release over periods of days or weeks. The dramatic change of 
dissolution prolife for 10ASP10HT and 30ASP10HT is caused by the exfoliation of HT as 









Figure 5.18  Immediate-release dissolution profiles (pH 7.4) (●) ASP, (◊) 10ASP, (□) 





























Figure 5.19  Immediate-release dissolution profiles (pH 7.4) in the first 6 hours of (●) 




Both 10ASP10HT and 30ASP10HT were not fully dissolved at the end of the 
dissolution test. A small fraction of the 10ASP10HT sample remained after undergoing 24 
hours of dissolution while approximately 30-40% of the 30ASP10HT disc was left after 
about 48 hours.  
An additional study was conducted by placing the 30ASP10HT samples in a 
beaker containing 1000 mL of pH 7.4 medium. A magnetic stirrer rotating at high speed 
was used to provide intensive mixing while the temperature was kept at 37°C. The time 
required for the discs to be fully dissolved was approximately 24 hours, resulting in a 




























 L100-55, are not altered and therefore, the change of the 
dissolution profile is due to the interaction between ASP and HT.  
Polarized light microscopy images of the remaining 30ASP10HT disc after 48 
hours of dissolution are shown in Figure 5.21. There is an opaque white layer adhering to 
the transparent layer of Eudragit
®
 L100-55 (Figure 5.21 (a)) while this layer is illuminated 
in black color at 0° position (Figure 5.21 (b)). In the 0° position, ASP and HT are shown 
in black (Figure 5.20 (b) and (d)). Hence, this white layer is presumably a complex or salt 
of ASP-Al and ASP-Mg which is not dissolved within 48 hours under the standard 




Figure 5.20  Polarized light microscopy of (a) ASP at 75° position (b) ASP at 0° position 












Figure 5.21   Polarized light microscopy of remaining 30ASP10HT after 48 hours of 













The heat flow of 30ASP10HT residue is measured using DSC from 25-500°C 
(Figure 5.22). Two broad endothermic peaks centered at approximately 200°C and 350°C 
could be the ASP-metal complex as observed in polarized light microscopy since HT also 
shows two endothermic peaks but at higher temperatures (270°C and 425°C).  
 
Figure 5.22  DSC heating results of (a) ASP, (b) HT, (c) 30ASP10HT residue. 
 
The release of ASP from 10ASP10HT can be explained as follows: the exfoliated 
HT greatly increases the tortuosity which is observed in SEM images as more distribution 
of small HT particles throughout the cross-sectional area. Once the medium reaches the 
ASP-intercalated HT, ion-exchange and dissolution of ASP occur similarly to 5ASP10HT. 










degree of dispersion of the exfoliated HT. Note that 10ASP10HT also contains free ASP 
and the dissolution profile is controlled by the release of  both free ASP and intercalated 
ASP, which, as mentioned earlier, cannot be quantitatively distinguished.  
For 30ASP10HT, the higher HT degree of exfoliation is confirmed by XRD 
spectra and the percolating structure observed by SEM; this could be due to the formation 
of an ASP-metal salt as discussed in sections 5.1 and 5.3.  The exfoliated HT greatly 
inhibits the diffusion of the medium to dissolve the free ASP; this results in approximately 
65% ASP released over 48 hours. The remaining 35% ASP could be the ASP in the form 
of the ASP-metal complex which might require more than 48 hours to be released or a 
higher mixing intensity as shown by the magnetic stirrer study. Kaniwa and coworkers 
studied the bioavailability of aspirin vs. aspirin aluminum tablets (Kaniwa et al., 1981). 
The release rate of ASP from aspirin aluminum tablets was significantly slower than that 
of ASP tablets and the bioavailability was nearly 60% of that from ASP tablets. The 
authors conclude that the low bioavailability of ASP from aspirin aluminum tablets was 
caused by the slow release of ASP from the aluminum/ASP complex. The rate limiting 
step was the stage of release of free ASP from the metal complex.  
The data in Table 5.3 are calculated using a curve fitting tool in MATLAB
®
 with 
95% confidence interval (CI) and R
2
 greater than 0.99. Table 5.3 also provides 
information on Eudragit
®
 L100-55 processed with only ASP as reported in Chapter 4 in 
order to compare the impact of added HT as a nanofiller. With only ASP in the polymer 
matrix (10-30%ASP), the exponent values in the Power Law Equation are between 0.5-1.0 
indicating non-Fickian transport (Ritger and Peppas, 1987). At low ASP concentration, the 







while at ASP loadings of 30% the n value of 0.59 is close to 0.5, associated with diffusion 
contribution. For polymer nanocomposites the exponent n values are also between 0.5-1.0 
showing similar tendency of reduced n at higher ASP loadings. However, the rate 
constants responsible for diffusion (k1) in the Peppas and Sahlin equation decrease with 
increasing ASP concentration in the polymer nanocomposites (Peppas and Sahlin, 1989). 




  (Equation (4.2)), the decrease of k1 indicates reduced diffusion 
coefficient, in other words, diffusion of the phosphate medium to the polymer 
nanocomposites samples while the ASP/Eudragit
®
 L100-55 samples exhibit an opposite 
trend.  
Ha and Xanthos reported values of n = 0.75 and 0.92 for the matrix of Eudragit
®
 
S100 containing 4%w/w diclofenac sodium and 10%w/w diclofenac/HT hybrid, 
respectively (Ha and Xanthos, 2011). The release mechanism for both samples was non-
Fickian (0.5 < n < 1.0). However, the addition of the nanoclay hybrid has altered the 
release mechanism toward erosion. Yang and coworkers investigated the effect of 
nanoclay MMT on the property of acetaminophen-poly(ethylene glycol) matrix (Yang et 
al., 2010). The n value decreased form 1 for acetaminophen-poly(ethylene glycol) to about 
0.7 for acetaminophen-MMT-poly(ethylene glycol), indicating that  the drug release 
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10ASP 0.86 ± 0.06 1.18 ± 0.44 0.43 ± 0.05 
20ASP 0.78 ± 0.08 1.97 ± 0.63 0.36 ± 0.07 
30ASP 0.59 ± 0.15 3.78 ± 1.66 0.18 ± 0.22 
    
5ASP10HT 0.86 ± 0.09 1.44 ± 0.47 0.23 ± 0.04 
10ASP10HT 0.78 ± 0.02 0.95 ± 0.13 0.13 ± 0.01 
30ASP10HT 0.70 ± 0.04 0.71 ± 0.11 0.02 ± 0.01 
1
 Ritger and Peppas, 1987 
2
 Peppas and Sahlin, 1989 
 
 
The delayed-release profile (Figure 5.23) is generated in order to investigate the 
effect of added HT to the nanocomposites integrity in acidic medium (stomach condition) 
and the change of the release profile once the pH is raised to 7.4 (small intestine 
condition). The HT is dissolved in acidic solution producing MgCl2 and AlCl3 (Ha, 2011). 
The dissolution of diclofenac/HT hybrid in pH 1.2 medium showed rapid release of 
diclofenac since the HT was quickly dissolved (Ha, 2011).  Therefore, the dispersed HT in 
the nanocomposites might have an effect on the release profile when the composites are 
exposed to acidic conditions. All formulations met the USP32 delayed-release dissolution 
criteria since less than 10% ASP was released within two hours in the acid stage. In fact, 
the ASP released was found to be 3.0%, 6.2% and 6.1% for 5ASP10HT, 10ASP10HT and 
30ASP10HT, respectively. After the pH was adjusted to pH 7.4, the dissolution profiles 
were similar to those of the immediate release study shown in Figure 5.18. Thus, the 
nanocomposites, in spite of the sensitivity of the hydrotalcite filler to low pH media, can 
withstand acidic conditions in the polymer used and maintain controlled release 








Figure 5.23  Delayed-release dissolution profile of  (◊) 10ASP, (∆) 30ASP(■) 




5.7 Rheological Results 
Structural characterization and quantification of HT dispersion were investigated using 
rheological methods. The following points are worth mentioning when the 
nanocomposite samples were tested at 100°C: a) measurements are made above the Tg of 
most samples, b) ASP dissolves at elevated temperatures acting as a plasticizer, c) 
depending on the composition HT can exist in different degrees of 
agglomeration/exfoliation. As a result, viscosity measurements were performed at 80°C 
as shown in Figure 5.24.  The viscosity is in the order of 30ASP10HT > 10ASP10HT > 




























Figure 5.24  Viscosity vs. frequency curves measured at 80°C of  (■) 5ASP10HT, (♦)  
10ASP10HT, (▲)  30ASP10HT. 
 
 
5.8 WVT Results 
The permeability of the polymer can be altered by the presence of the nanoclays 
depending on their concentration, volume fraction, particle size, morphology, platelet 
orientation, etc. In general, adding impermeable nanoclays into the polymer results in 
decreased permeability due to an additional pathway (tortuosity) for solvents to pass 
through. The tortuosity can be further enhanced if nanoclays are fully dispersed to single 
platelets (exfoliation) compared to stacks of multiple platelets (agglomeration). 
 The barrier properties of the plasticized-polymer (without nanoclays) and polymer 
nanocomposites were tested using the ASTM E-96 standard water vapor method at room 

























hours (7 days) was plotted vs. time and the water vapor transmission rate (WVTR) was 
calculated from Equation (5.1).  
  
WVTR = (G/t)/A (5.1) 
 
Where G is weight change from the straight line in g; t is time in hours; A is the test area 
(cup mouth area) in m
2
. Note that, in this equation the sample thickness is not taken into 
account as suggested by ASTM E-96. Calculated WVTR values are shown in Tables 5.4 
and 5.5.   
 
Table 5.4  WVTR of Polymer Nanocomposites 
Sample Thickness Slope Cup mouth 
area 
WVTR Average WVTR 









TEC/EUL 0.2634 0.0262 0.00181 14.486 13.823 331.74 
 0.2146 0.0238 0.00181 13.159   
       
10HT 0.2547 0.0211 0.00181 11.666 11.279 270.70 
 0.2355 0.0197 0.00181 10.892   
       
5ASP10HT 0.2479 0.0171 0.00181 9.455 9.842 236.20 
 0.2974 0.0185 0.00181 10.229   
       
10ASP10HT 0.2273 0.0139 0.00181 7.685 7.519 180.47 
 0.2758 0.0133 0.00181 7.354   
       
30ASP10HT 0.2147 0.0036 0.00181 1.990 2.101 50.42 












Table 5.5  Normalized WVTR of Polymer Nanocomposites 











TEC/EUL 0.2634 14.486 3.816 3.320 
 0.2146 13.159 2.824  
     
10HT 0.2547 11.666 2.971 2.768 
 0.2355 10.892 2.565  
     
5ASP10HT 0.2479 9.455 2.344 2.693 
 0.2974 10.229 3.042  
     
10ASP10HT 0.2273 7.685 1.747 1.887 
 0.2758 7.354 2.028  
     
30ASP10HT 0.2147 1.990 0.427 0.511 
 0.2687 2.212 0.594  
 
It is clear that the WVTR of the nanocomposites depends on the type of additive 
(HT vs. ASP/HT combinations) and the relative ratio of ASP/HT. It also appears that the 
system with the highest degree of HT exfoliation and slowest ASP release resulted in the 
lowest WVTR i.e. lowest permeability. 
 
5.9 Mechanism of Intercalation and Exfoliation 
The proposed mechanism taking place during the melt mixing in this study is illustrated 
in Figure 5.25. Without ASP in the formulation, HT is uniformly dispersed in the molten 
Eudragit
®
 L100-55 during melt mixing in the batch mixer and present in an agglomerated 
form as the sample is cooled down to room temperature (Figure 5.25 (a)). The addition of 
ASP gradually changes the morphology of HT as a function of the ASP concentration. In 
the case of 5ASP10HT, ASP is first dissolved in the molten Eudragit
®
 L100-55.  Ion 
exchange then follows between the anionic ASP and the carbonate anions entrapped in 







intercalation process of ASP occurs as illustrated in Figure 5.24 (b). However, not all of 
HT molecules have intercalated ASP since the amount of ASP in the 5ASP10HT 
formulation is lower than the HT’s AEC. Hence, there are HT particles left in a 
agglomerated phase.  
Increasing the amount of ASP to 10% results in more ASP-intercalated HT 
molecules. Furthermore, exfoliated HT particles would have also been found in the 
10ASP10HT sample. This could arise from the fact that the ratio of ASP to HT exceeds 
the AEC of HT (6.13 g of ASP to 10 g of HT). Since the mixing was carried out in the 
confined space of the batch mixer, therefore, there is a possibility that some HT 
molecules were continuously intercalating a higher amount of ASP during mixing.  An 
excess ASP being forced to HT interlayer created unbalanced charge of MgAl(OH) 
positive layer, leading to the separation of HT layers.  
When 30% ASP was mixed with 10%HT in the molten Eudragit
®
 L100-55, a 
significant amount of ASP interacted with HT and resulted in much faster separation of 
the HT platelets compared to the other two formulations as shown in the onset of 
increasing torque after a certain mixing time. The amount of separated platelets is also 
higher than for 10ASP10HT. These exfoliated platelets bonded with ASP molecules 
through Al or Mg salts and formed a percolating network as the nanocomposites were 










Figure 5.25  Proposed mechanism of intercalation and exfoliation in polymer 












L100-55, various CAF concentrations ranging from 10%-30%w/w 
are shown in Table 6.1.  
Table 6.1 Sample Formulations Prepared by Hot-melt Mixing 









10CAF 10 18 72 
20CAF 20 16 64 
30CAF 30 14 56 
 
Solubility parameters obtained from the literature are shown in Table 6.2. The 
difference of solubility parameters among CAF, TEC and Eudragit
®
 L100-55 shown in 
Table 6.2 is approximately 5.7-6.9, slightly close to maximum limit for a miscible system 
(difference in solubility parameter, 7.0).  
 
Table 6.2 Solubility Parameters (MPa
1/2









  26.8 22.2 21.1 
Hansen
2
 25.6 20.9 22.3 
Partial least square regression
3
 28.0 - - 
Experimental
4
 26.7 - - 
1
 Bustamante et al., 2011. Hildebrand solubility parameter to predict drug release from hydroxypropyl 
methylcellulose gels. 
2
 Hansen, 2004. Polymer additives and solubility parameters. 
3
 Tantishaiyakul et al., 2006. Prediction of solubility parameters using partial least square regression. 
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6.1 Mixing Process Monitoring 
The evolution of torque for CAF/Eudragit
® 
L100-55 is shown in Figure 6.1. Decreasing 
torque during mixing observed in Figure 6.1 indicated that CAF was dissolved in the 
molten Eudragit
® 





Figure 6.1 The evolution of torque of CAF/Eudragit
® 
































6.2 FTIR Results 
The FTIR spectra of CAF, Eudragit
® 
L100-55 are shown in Figure 6.2. CAF contains two 
carbonyl groups (>C=O) showing peaks between 1660-1700 cm
-1
 and one C=N with 
corresponding peaks in the range of 1640-1690 cm
-1
. Hence, superimposed peaks are 
depicted at 1658 and 1701 cm
-1
 (Paradkar and Irudayaraj, 2002; Socrates, 2001). The 
peak at 1025 and 1359 cm
-1
 is attributed to the stretching mode of C-N. The C-H bond 
(stretching mode) of methyl group of the cyclic structure is shown at 2955 cm
-1
. No new 
peaks are observed in the CAF/Eudragit
® 
L100-55 samples while the intensity of the CHx 
vibration attributed to the Eudragit
® 
L100-55 shown at 1400 cm
-1
 decreased with 
increasing CAF loading. The characteristic peaks of CAF are clearly pronounced in 







Figure 6.2 FTIR spectra of (a) CAF, (b) pristine Eudragit
®
 L100-55, (c) TEC/EUL, (d) 






































6.3 XRD Results 
From Figure 6.3 (a), CAF appears as a highly crystalline API like ASP due to the 
presence of several sharp peaks in the XRD spectrum. The processed samples (Figure 6.3 
(d), (e) and (f)) also show strong peaks at the 2 of the CAF’s characteristic peaks, 
indicating that crystals of CAF are dispersed in the polymer matrix. Similarly to the ASP 
study CAF was dissolved in the Eudragit
® 
L100-55 in the batch mixer and recrystallized 
at room temperature. Experimental results are quite in agreement with the miscibility 




Figure 6.3  XRD spectra of (a) CAF, (b) pristine Eudragit
®
 L100-55, (c) TEC/EUL, (d) 




























6.4 Dissolution Tests 
The dissolution profile for CAF/Eudragit
®
 L100-55 under pH 7.4 medium is shown in 
Figure 6.4. A sustained-release profile is obtained in the CAF/Eudragit
®
 L100-55 system. 
After two hours of dissolution, CAF was released at 69.7%, 80.9% and 83.0% for 
10CAF, 20CAF and 30CAF, respectively. In all formulations CAF release reached 
approximately 95% after three hours. Compared to ASP/Eudragit
®
 L100-55 with 
identical API loading, ASP in all three concentrations (10%-30%) was released roughly 
65% after two hours. CAF has higher solubility than ASP in pH 7.4, resulting in faster 
release rate.  The curve fitting to power law and Pappas and Sahlin equations is shown 





Figure 6.4  Immediate-release dissolution profiles (pH 7.4) of (x) CAF, (◊) 10CAF, (□) 








































 + k2t 








10CAF 0.85 ± 0.03 1.31 ± 0.37 0.47 ± 0.05 
20CAF 0.87 ± 0.03 1.11 ± 0.20 0.65 ± 0.03 
30CAF 0.92 ± 0.04 0.65 ± 0.20 0.65 ± 0.03 
1
 Ritger and Peppas, 1987 
2












CAF loading in the polymer nanocomposites is varied from 5%-10%w/w while MMT 
was added at 10%w/w in all formulations. The TEC to Eudragit
®
 L100-55 weight ratio 
was fixed at 1:4 in CAF/MMT/Eudragit
® 
L100-55. The amount of CAF in the 
formulations was above CEC values of MMT which 1.80 g of CAF per 10 g of MMT 
(Appendix B). 
 
Table 7.1 Sample Formulations Prepared by Hot-melt Mixing 
System Formulation Components (%wt) 







10MMT - 10 18 72 
      
API/nanoclays/ 
plasticizer-polymer 
5CAF10MMT 5 10 17 68 
10CAF10MMT 10 10 16 64 
30CAF10MMT 30 10 12 48 
 
7.1 Mixing Process Monitoring  
The evolution of torque for CAF/MMT/Eudragit
® 
L100-55 is demonstrated in Figure 7.1. 
In the presence of MMT, CAF/MMT/Eudragit
® 
L100-55 samples also showed gradual 
decrease of torque toward the end of the mixing process. Therefore, it is suggested that 
no strong interactions occurred among CAF, MMT and Eudragit
® 
L100-55. There was a 
human error when the 5CAF10MMT pre-mixed sample was added to the batch mixer, 












L100-55 during melt mixing. 
 
7.2 FTIR Results 
Figure 7.2 contains FTIR spectra of MMT and CAF/MMT/Eudragit
® 
L100-55 
nanocomposites. For MMT, the peaks at 3632 and 3437 cm
-1
 are the stretching vibration 
of the O-H bonds in Al-OH and absorbed water in the interlayers.  The Si-O stretching 
(in-plane) vibration and the Al-Al-OH bending vibration in the octahedral layer 
correspond to the peaks at 1026 and 917 cm
-1
, respectively (Joshi et al., 2010). The Si-O 
bending vibration appears at 529 cm
-1
 (Fan, 2011). In Figure 7.2 (c), 10MMT shows 
MMT’s peaks centered at 1027 and 463 cm
-1
 attributed to Si-O stretching (in-plane) 




























for the esterified group and the carboxylic group of Eudragit
® 
L100-55 are observed at 
1737 and 1703 cm
-1
, respectively. The CHx vibration of Eudragit
® 
L100-55 still 
dominates at 1400 cm
-1
.  All CAF/MMT/Eudragit
® 
L100-55 nanocomposites display both 
characteristic peaks of MMT and CAF at their original wavelengths. There are no new 







Figure 7.2  FTIR spectra of (a) CAF, (b) MMT, (c) 10MMT, (d) 5CAF10MMT, (e) 





























7.3 XRD Results 
XRD spectra of the polymer nanocomoposites are illustrated in Figure 7.3. Two sharp 
peaks of MMT as observed in Figure 7.3 (b) are associated with planes (001) and (002) 
(Patel et al., 2006). The strong peak around 7.50 indicates that the original basal spacing 
(d001) is 1.17 nm. In Figure 7.3 (c), 10MMT exhibits identical peaks as found in MMT 
which suggests that no interactions between polymer chain and MMT occur. This lack of 
change of the 10MMT basal space was similar to that of the 10HT in anionic system 
reported in Chapter 5. However, as the API is introduced to nanoclays/polymer, a 
difference is shown between the cationic polymer nanocomposites (CAF/MMT/Eudragit
®
 
L100-55) and the anionic nanocomposites (ASP/HT/Eudragit
®
 L100-55). d001 of MMT 
located at 7.50 is  shown in all CAF/MMT/Eudragit
®
 L100-55 nanocomposites (Figure 
7.3 (d), (e) and (f)) without any shift of the 2 angle whilst the characteristic peaks of 
CAF are found at the original 2 angle except for 5CAFF10MMT due to the low 
concentration of CAF. The lack of change of the location of the MMT d001 implies that 
intercalation does not take place upon the addition of CAF to MMT/Eudragit
®
 L100-55 
which was not the case for the anionic nanocomposites systems. One plausible reason is 
that CAF is a weak base (pKa = 14.0), therefore CAF is less likely to be protonated. 
MMT processed with acetaminophen (pKa =9.51) and poly(ethylene glycol) in the 
identical batch mixer (50 rpm and 100°C for 6 minutes) also show gradual decreased 
torque toward the end of melt mixing; MMT in the processed sample was presence in 
agglomeration phase according to XRD spectrum (Yang et al., 2010). The intercalation of 
dapsone into MMT was successfully conducted by adding ionized dapsone solution into 







Dapsone has two pKa values, 1.3 and 2.4 due to two ionizable amino groups (Fan, 2011). 




Figure 7.3  XRD spectra of (a) CAF, (b) MMT, (c) 10MMT, (d) 5CAF10MMT, (e) 
10CAF10MMT, (f) 30CAF10MMT. 
 
 
7.4 Dissolution Tests 
In the presence of MMT, the release of CAFF was prolonged to a certain degree (Figure 
7.4). After 3 hours, CAF release was found to be 77.2%, 79.9% and 83.2% for 
5CAF10MMT, 10CAF10MMT and 30CAF10MMT, respectively. To achieve roughly 
95% CAF release, all formulations required up to six hours of dissolution as compared to 
only three hours in the formulations without MMT.  
























Yang et al. studied the binary and ternary mixtures of acetaminophen (APAP), 
MMT (Closite
®
 15A and Closite
®
 30B) and poly(ethylene glycol) (PEO) prepared by 
hot-melt mixing using the batch mixer as used in this work (Yang et al., 2010). The 
complete release of APAP from the binary system (APAP/PEO) was roughly one hour 
while for the ternary system (APAP/MMT/PEO) was 6 hours.  Furthermore, the contact 
angle of the dissolution medium on the surface of 10APAP is ten degrees smaller than 
10APAP10Closite
®
 30B). Hence, it was suggested that the retardation in the release was 




Figure 7.4  Immediate-release dissolution profiles (pH 7.4) of (■) 5CAF10MMT, (♦) 



























According to XRD results, the morphology of MMT in all CAF/MMT/Eudragit
®
 
L100-55 composites contains an agglomerated phase.  In the presence of MMT for 90% 
release the dissolution time was extended from three hours (CAF/Eudragit
®
 L100-55) to 
six hours (CAF/MMT/Eudragit
®





 L100-55 samples contained HT with intercalation and 
exfoliation phases resulting in the tremendous prolonged-release of ASP from the 





 L100-55.    
 
Table 7.2 %API Release of Anionic and Cationic Polymer Nanocomposites  
Sample Time 
(hour) 
%API released (pH 7.4 medium) 
10ASP 10ASP10HT 10CAF 10CAF10MMT 
10%API 0.5 18.5 6.5 21.0 21.0 
 1 35.0 12.0 39.8 38.2 
 2 63.2 21.2 69.7 63.1 
 3 82.4 29.8 93.3 79.9 
 4 92.9 40.4 97.8 85.7 
 5 96.3 47.4 98.3 89.7 
 6 95.0 55.2  93.3 
 8  70.0   
 12  79.3   
 24  88.1   
      
Sample Time 
(hour) 
30ASP 30ASP10HT 30CAF 30CAF10MMT 
30%API 0.5 24.5 5.5 25.6 24.8 
 1 38.9 7.0 47.9 45.6 
 2 66.5 10.1 83.0 74.0 
 3 88.4 12.7 96.2 83.2 
 4 98.0 15.7 98.6 86.7 
 5 95.9 18.5 99.5 90.1 
 6 92.6 20.1  94.3 
 8  25.7   
 12  37.6   








The dissolution data are plotted to fit Power law and Peppas and Sahlin equations 
as shown in Table 7.3. According to power law equation, the n value of both 
CAF/Eudragit
®
 L100 and CAF/MMT/Eudragit
®
 L100 is between 0.5-1.0, indicating non-
Fickian release mechanism.  
 












 + k2t 








10CAF 0.85 ± 0.03 1.31 ± 0.37 0.47 ± 0.05 
20CAF 0.87 ± 0.03 1.11 ± 0.20 0.65 ± 0.03 
30CAF 0.92 ± 0.04 0.65 ± 0.20 0.65 ± 0.03 
    
5CAF10MMT 0.83 ± 0.03 1.33 ± 0.38 0.40 ± 0.04 
10CAF10MMT 0.83 ± 0.03 1.79 ± 0.48 0.50 ± 0.05 
30CAF10MMT 0.81 ± 0.03 1.78 ± 0.57 0.50 ± 0.07 
1
 Ritger and Peppas, 1987 
2














CONCLUDING REMARKS AND SUGGESTED FUTURE STUDIES 
 
8.1 Summary 
Four modified-release systems were investigated in this dissertation. All systems were 
prepared by HMM in the batch mixer. The carrier was poly(methacrylic acid-co-ethyl 
acrylate), Eudragit
®
 100-55 which is designed to be dissolved in water above pH 5.5. The 
first system discussed in Chapter 4 was the enteric matrix containing thermally-sensitive 
anionic API (ASP) while the second system reported in Chapter 5 was the polymer 
nanocomposite containing the same API but with the addition of anionic nanoclay (HT) 
in order to modify the API release from the original enteric matrix. The second API, 
CAF, representing a cationic API was investigated as the third system in Chapter 6. The 
fourth system included the addition of a cationic nanoclay (MMT) to the third system and 
was reported in Chapter 7.    
 For the first system, preliminary studies based on thermal analysis were used to 
determine the optimum processing conditions. Samples of the enteric matrix containing 
10-30%w/w of ASP were successfully prepared without significant degradation of ASP. 
The ASP was recrystallized upon cooling to room temperature at all three concentrations, 
indicating an immiscible system even if a miscible system was suggested by applying 
solubility parameters estimation based on Hildebrand and Hansen methods. Therefore, 
these ASP-enteric matrix samples can be classified at room temperature as solid 
dispersions and, more specifically, glass suspensions in which a crystalline API is 







temperatures where ASP acted as a plasticizer by reducing the Tg and melt viscosity of 
the matrix. The crystalline form of ASP in the matrix at room temperature was confirmed 
by XRD and SEM. Degree of crystallinity and ASP loading showed no significant impact 
on dissolution profiles for either immediate or delayed-release. In the delayed-dissolution 
test, an enteric property (resistance to acidic pH) was obtained and the sustained-release 
profile was exhibited as the pH value was raised to 7.4. The API release mechanism 
using power law was non-Fickian (0.5<n<1.0) and the tendency approached diffusion 
(n=0.5) with increasing ASP concentrations. The curved fitting to Peppas and Sahlin 
equation showed also higher diffusion coefficient at higher ASP loading. This enteric 
matrix would be suitable for low-dose ASP (60-81 mg) dosage form. With 30%w/w of 
ASP, the final enteric tablet (matrix) can be approximately 180-240 mg which is the size 
of regular tablets. Therefore, HMM can deliver an enteric dosage form by dispersing API 
in the enteric polymer; this technique allows fewer unit operations compared to the 
enteric-coated tablet process.  
 The second system can be considered as a polymer nanocomposite since the 
additional component was nanoclays typically employed in plastic-based materials. The 
dispersion of the impermeable nanoclays is expected to reduce the nanocomposite 
permeability. Limited dispersion of HT in Eudragit
®
 100-55 was found (no intercalation 
or exfoliation), suggesting poor chemical affinity between the polymer and the selected 
nanoclay or inadequate processing conditions. With the addition of ASP, HT dispersion 
was dramatically improved resulting in change of the HT morphology from 
agglomeration to exfoliation.  From a polymer engineering perspective, ASP in this work 







dependent on the ASP concentrations. The intercalation of HT may occur by the insertion 
of both ASP molecules and Eudragit
®
 L100-55 polymer chains. More than 1 phases of 
HT were apparent for the two lowest ASP concentrations (5% and 10%ASP) and reduced 
permeability was observed from both dissolution and water vapor transmission studies. 
The agglomerated HT and ASP-intercalated HT were found in 5ASP10HT, resulting in 
slightly prolonged release of ASP in the pH 7.4 dissolution test compared to 
ASP/Eudragit
®
 L100-55 samples. 10ASP10HT also exhibited two phases but somewhat 
different from 5ASP10HT being ASP-intercalated HT and partially exfoliated HT. The 
partially exfoliated HT dispersed throughout the nanocomposite increased the tortuosity 
and thus significantly retarded permeation of pH 7.4 medium to penetrate and dissolve 
ASP molecules. 
The highest ASP concentration (30%w/w) produced the lowest permeation as a 
result of the dispersion of exfoliated HT. This may also be related to the AEC of the HT. 
During HMM in the batch mixer, the amount of ASP above the HT’s AEC (as for 
example, 30%ASP per 10%w/w HT) led to (a) the delamination of HT to individual HT 
platelets, (b) some ASP molecules to be bonded with these HT platelets and form ASP-Al 
and ASP -Mg salts and (c) recrystallization of the remaining ASP molecules as free ASP 
when the sample was cooled down. Hence, AEC is a factor that should be considered 
when the added component has a potential interaction with the nanoclay. According to 
the power law the API release mechanism was determined to be Non-Fickian However, 
the diffusion coefficient determined from the Peppas and Sahlin equation decreased with 







It is not always the case in which strong interactions between API and nanoclay 
occurs during melt mixing, resulting in the modification of the nanoclay’s morphology 
(intercalation and exfoliation). 10%w/w MMT was processed with 10%w/w ASP under 
identical HMM conditions (Appendix C) without any dramatic increase of torque during 
the entire 5-minute mixing time. MMT was found in an agglomerated phase and the 
release profile of ASP was slightly prolonged compared to ASP/Eudragit
®
 L100-55 
samples but was not as long as for the ASP/HT/Eudragit
®
 L100-55 samples. 
In the third system, 10%-30%w/w of CAF was processed with plasticized 
Eudragit
®
 L100-55 under identical conditions as for the first system. CAF in crystalline 
form was observed in the API/polymer blends after cooling; the calculated solubility 
parameters estimated by Hildebrand and Hansen methods suggest nearly immiscible 
system (difference in solubility parameters 5.7-6.9 MPa
1/2
). The API release mechanism 
according to the power law was non-Fickian in all formulations (0.5<n<1.0). The release 
rate of CAF (CAF/Eudragit
®
 L100-55) in pH 7.4 medium was slightly faster than ASP 
(ASP/Eudragit
®
 L100-55) due its higher aqueous solubility.  
The fourth system was classified as polymer nanocomposites as the second 
system but with a cationic API and an anionic nanoclay. All CAF concentrations in the 
formulation (10%-30% w/w CAF) exceeded the CEC of MMT (Appendix B). However, 
the melt mixing of CAF and MMT did not reveal strong interactions as those that 
occurred in the ASP/HT study. MMT was present in an agglomerated phase in the 
nanocomposites containing only MMT and all CAF concentrations (10%-30%w/w). The 
CAF release in the pH 7.4 medium from CAF/MMT/Eudragit
®
 L100-55 was slightly 
slower compared to CAF/Eudragit
®







not significantly retard the release rate of CAF from CAF/MMT/Eudragit
®
 L100-55 as 
well as the release of ASP from ASP/MMT/Eudragit
®
 L100-55. The API release 
mechanism was also determined to be non-Fickian. The unchanged morphology of MMT 
could be due to the low affinity of CAF to MMT since CAF is a weak base (pKa of 14.0). 
 
8.2 Future Studies 
8.2.1 Extension of the ASP/HT/Eudragit
®
 L100-55 Hot-Melt Mixing (HMM) System 
to Hot-Melt Extrusion (HME) 
HMM provides information on processing parameters, for example, screw speed, torque, 
temperature, and residence time which can be used to provide useful data for a transition 
to an HME operation. For example, the HMM mixing time to reach a steady state of 
torque and temperature was approximately 120-150 s in all ASP/Eudragit
®
 L100-55 
formulations. This information might be used to estimate the minimum residence time for 
HME in order to ensure that the homogenous mixture (API and polymer in the rubber 
state) is obtained. 
 
8.2.2 Polymer Nanocomposites with a Combination of Two APIs 
ASP/Eudragit
®
 L100-55 and CAF/Eudragit
®
 L100-55 were studied individually. It would 
be of interest to investigate the combination of ASP and CAF in one polymer blend. 
ASP/CAF is commercially available in the market as tablets (Anacin
®
: 400 mg ASP and 
32 mg CAF). Limited studies are conducted on a polymer matrix associated with 
HME/HMM and containing more than one API. Both ASP and CAF are present in 
crystalline forms in plasticized Eudragit
®
 L100-55. However, the CAF has higher 







might be different even if both API’s are released from the polymer matrix in crystalline 
form. The addition of the nanoclays can also be included in an extended study containing 
a combination of APIs. The nanoclay should be selected carefully to avoid strong 
interaction among all components. MMT could be an appropriate candidate due to low 
ionic exchange capacity and demonstrated success in its processing with HME.       
 
8.2.3 Polymer Nanocomposites Using Polymer without Carboxylic Groups 
It is of interest that the carboxylic groups of Eudragit
®
 L100-55 may react with Al and 
Mg in HT. A future investigation employing identical API and nanoclays i.e., ASP and 
HT, but a polymer without carboxylic groups such as Eudragit
®
 E100 or Eudragit
®
 E PO 







CALCULATION FOR ANION EXCHANGE CAPACITY (AEC) 
 
AEC is calculated as follows: 
Equivalent weight = formula weight divided by the total valence 
 
    
            
                                 
 
 
   
                                       
       
 
 
                
                                 
       
 
 
ASP’s molecular weight = 180.15 g and has 1 valence at the carboxylic group. 
 
                    




                             
 
          
        
    
  
 
                   
 
 
The reported AEC of HT is 3.4 mEq/g; 10 g of HT is equal to 34 mEq. 
 
           
            
 
               
          
 
 
            
 
Since 34 mEq of ASP is equal to 6125.1 mg or 6.1251 g. Therefore, 10 g of HT can 






CALCULATION FOR CATIONIC EXCHANGE CAPACITY (CEC) 
 
CEC is calculated as follows: 
Equivalent weight = formula weight divided by the total valence 
 
    
            
                                 
 
 
   
                                       
       
 
 
                
                                 
       
 
 
CAF’s molecular weight = 194.2 g and has 1 valence at the tertiary amine of the 
imidazole ring. 
 
                    




                            
 
          
       
    
  
 
                  
 
 
The reported CEC of MMT is 0.926 mEq/g; 10 g of MMT is equal to 9.26 mEq. 
 
           
              
 
              
          
 
 
            
 
Since 9.26 mEq of CAF is equal to 1798.3 mg or 1.7983 g. Therefore, 10 g of MMT can 










The formulation of ASP with cationic clays, MMT was prepared under similar hot-melt 
mixing condition (100°C for 5 minutes in the batch mixer). The formulation and 
characterization information are illustrated in this Appendix. 
 
Table C.1 Sample formulations prepared by hot melt mixing 
System Formulation  Component (%wt) 






10ASP10MMT 10 10 16 64 
 
In Figure C.1, torque gradually decreases suggesting the dissolution of ASP in the 
molten polymer and no strong interactions between ASP, MMT and Eudragit
®
 L100-55.  
 




























Figure C.2 (f) shows the XRD spectra of 10ASP10MMT. The MMT’s peak is not 
shifted to lower angle, indicating no intercalation whereas the crystalline peaks of ASP 
are also shown at the original 2 angle. Therefore, MMT is found in the agglomerated 




Figure C.2  XRD spectra of (a) ASP, (b) HT, (C) MMT, (d) 10ASP10HT, (e) 































The release rate of ASP from 10ASP10MMT illustrated in Figure C.3 is slightly 
slower than ASP/Eudragit
®
 L100-55 but still faster than ASP/HT/Eudragit
®
 L100-55. 
This is due to the agglomeration of MMT which decreases the wettability of the polymer 
nancomposites. The degree of inhibited release rate caused by agglomeration of the 




Figure C.3  Immediate-release dissolution profiles (pH 7.4) of  (●) ASP, (◊) 10ASP, (□) 


























THERMAL STABILITY OF API/POLYMER MIXTURES AND 
API/NANOCLAY/POLYMER COMPOSITES 
 
Figure D.1 shows the TGA results of physical mixtures and processed samples of 
TEC/EUL, 10ASP and 30ASP. The weight lost between physical mixture and processed 
samples of 10ASP and 30ASP is not significantly different.  
 
 
Figure D.1  TGA results of TEC/EUL, 10ASP and 30ASP.  Comparison between 















30ASP physical mixture 30ASP processed 10ASP physical mixture





Figure D.2 illustrates the weight loss of physical mixture and processed samples of 
10ASP10HT. The processed 10ASP10HT shows significant improvement of thermal 
stability compared to the physical mixture. It can imply that there are strong interaction 
between ASP, HT and Eudragit
®
 L100-55 or improved dispersion of HT which acts as a 
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